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Abstract 
Systemic investigation of protein-protein interactions has been instrumental in elucidating the complex 
molecular mechanisms underlying animal development. In C. elegans, early embryogenesis is a dynamically 
regulated process and provides an attractive model system for mapping in vivo protein interactions. In order 
to accurately identify specific interactions in C. elegans embryos, a new quantitative approach was 
developed combining in vivo expressed GFP fusion proteins with label-free interaction proteomics.  This 
strategy was applied to studying the interaction partners of eight bait proteins involved in essential 
biological processes during early embryogenesis. As a result, this study generated a pilot embryo in vivo 
interaction network composed of 559 interactions among 472 proteins. Importantly, this network captures 
not only well-characterized bindings but also new interactions of high functional relevance. Further utility of 
the network is demonstrated by combining it with RNAi perturbation to search for new regulators of P 
granule formation in early embryos. Consequently, a worm-specific protein GEI-12 was discovered as a novel 
interaction partner of the DYRK kinase MBK-2 and as an important regulator of P granule dynamics and 
germline maintenance. This leads to a hypothetical model in which the phosphorylation state of GEI-12 
mediates P granule assembly and disassembly during early embryogenesis. In addition, GEI-12 also induces 
granule formation in mammalian cells and interacts with PP2A phosphatases, indicating that the 
fundamental biophysical properties required for ribonucleoprotein granule formation are conserved across 
species during evolution. In summary, in vivo interactome mapping is a powerful and versatile approach that 
not only unravels the functional organization of the proteome but also can reveal invaluable biological 
insights into animal development. 
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Zusammenfassung 
Die systematische Untersuchung von Protein-Protein-Interaktionen hat wesentlich zum Verständnis der 
komplexen molekularen Mechanismen beigetragen, welche der Entwicklung von Tieren zu Grunde liegt. In C. 
elegans ist die frühe Embryogenese ein dynamisch regulierter Prozess und bietet ein attraktives 
Modellsystem, um Wechselwirkungen von Proteinen in vivo zu entschlüsseln. Zur präzisen Identifizierung 
von spezifischen Interaktionen im C. elegans Embryo wurde ein neuer quantitativer Ansatz entwickelt, 
welcher die Expression von Fusionsproteinen an grün fluoreszierendes Protein in vivo mit markierungsfreier 
Interaktionsproteomik kombiniert. Diese Strategie wurde angewandt, um die Interaktionspartner von acht 
Proteinen zu untersuchen, die in essentiellen biologischen Prozessen während der frühen Embryogenese 
involviert sind. Diese Studie liefert als Ergebnis ein erstes embryonales in vivo Interaktionsnetzwerk 
bestehend aus 559 Interaktionen zwischen 472 Proteinen. Dieses Netzwerk erfasst nicht nur bekannte 
Bindungen, sondern auch neue Interaktionen von hoher funktioneller Relevanz. Die Netzwerkinformationen 
wurden mit Experimenten auf Basis der Ribonukleinsäuren-Interferenz kombiniert um neue Regulatoren der 
sogenannten „P granules” (zelluläre Strukturen in der Keimbahn) ausfindig zu machen. Infolgedessen  wurde 
das fadenwurmspezifische Protein GEI-12  als neuer Interaktionspartner der DYRK-Kinase MBK-2 und als 
wichtiger Regler für die Dynamik der „P granules“ und für die Aufrechterhaltung der Keimbahn identifiziert. 
Dies führt zu einem hypothetischen Modell in welchem der Phosphorylierungszustand von GEI-12 den Auf- 
und Abbau der „P granules“ während der frühen Embryogenese vermittelt. Darüber hinaus veranlasst GEI-12 
auch die Entstehung von „P granules“ in Säugetierzellen und bindet an PP2A-Phosphatasen, was darauf 
hindeutet, dass die grundlegenden biophysikalischen Eigenschaften die zur Entstehung der 
Ribonukleoprotein-Körperchen notwendig sind, im Laufe der Evolution zwischen Spezies konserviert 
geblieben sind. Zusammenfassend stellt die in vivo Interaktionskartierung ein leistungsstarkes und 
vielseitiges Werkzeug dar, welches nicht nur die funktionelle Organisation des Proteoms aufdeckt, sondern 
auch wertvolle biologische Einsichten in die tierische Entwicklungsbiologie liefert. 
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I Introduction 
I.1. Protein-protein interaction 
Protein is of paramount importance in executing messages stored in the genome. The proteome, which 
could be loosely defined as the entire collection of proteins expressed by an organism, is not a simple flow 
from the genome or transcriptome. The dynamic range of a cellular proteome spans seven orders of 
magnitude (Zubarev, 2013). Furthermore, the complexity of the proteome is considerably amplified by post-
translational modifications (PTMs) of proteins, including phosphorylation, acetylation, methylation, 
glycosylation, ubiquitination, lipidation, proteolysis and many others. As a result, the tightly controlled yet 
intricate combination of different PTMs diversify protein functionalities, allowing fine-tuning of protein 
activity in response to various intra- and extra-cellular signals and biological needs. 
Proteins rarely act on their own, and in fact, most proteins are believed to be associated with other 
proteins and biomolecules to exert a plethora of molecular functions. Although each cell is packed with a 
large number of proteins, the localization and coordination of different proteins are beautifully programmed 
and regulated not only in a cell-autonomous fashion but also according to the functional needs of a wider 
physiologic system. The interactions between different proteins are therefore critically important in 
completing desirable molecular tasks for essentially every biological process. Given the fundamental 
importance of protein-protein interactions, it is not surprising, when out of proper control, aberrant 
pathologic protein-protein interactions also form the basis that drives the progression of many diseases, 
including a broad spectrum of neurodegenerative disorders and cancers (Ivanov et al., 2013; Ross and 
Poirier, 2005). 
To explore the functions of a protein, identifying its interaction partners gives a critical overview of the 
biophysical environment in which the protein exerts its functions. Such a picture allows for a mechanistic 
insight into the biological processes where these proteins are involved. At a systems level, comprehensive 
mapping of protein-protein interactions provides crucial details of the mechanical and functional 
organization of the proteome, which are instrumental in elucidating complex molecular phenomena. 
 I Introduction    
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The goal of the present thesis is to develop a new quantitative proteomic strategy to study protein-
protein interactions in vivo during early embryogenesis of Caenorhabditis elegans, with a biological sub-
focus on P granule dynamics. Therefore, in the next sections, current methodology to investigate protein-
protein interactions will be introduced. This is followed by an overview of P granule regulation during C. 
elegans early development and a brief summary of current knowledge on regulatory mechanisms of 
ribonucleoprotein (RNP) granule assembly/disassembly in other systems. 
 
I.1.1. Detection of protein-protein interactions 
From a physical chemistry point of view, protein-protein interaction is mediated primarily through non-
covalent intermolecular forces, including electrostatic interactions, hydrogen bonding, van der Waals forces, 
cation-π interactions and hydrophobic effect (Crowley and Golovin, 2005; Leckband, 2000). Despite being 
relatively weak individually, multiple interactions can occur at the binding interface and generate strong 
association between proteins. There’re various ways to classify protein-protein interactions into different 
categories, based on their composition, binding affinity and stability (Ozbabacan et al., 2011). According to 
the lifetime of their association, protein-protein interactions are generally described as stable or transient. 
Despite being conceptually different, they are also sometimes interchangeably perceived as strong or weak 
interactions, which in fact refer to their binding affinities. Well-characterized protein complexes are usually 
formed by stable interactions that maintain their integrity throughout lengthy biochemical purification, for 
example, the histone octameric core complex (Eickbush and Moudrianakis, 1978) and the core components 
of ribosomes and proteasomes (Fromont-Racine et al., 2003; Gu and Enenkel, 2014). However, many 
dynamic interactions are transient and weakly associated, and they are heavily involved in diverse cellular 
processes, such as signal transduction and protein synthesis (Gallie, 2002; Ozbabacan et al., 2011). 
Identifying these interactions poses a technically more challenging task. 
Over the last decades, new techniques for detecting protein-protein interactions have continually been 
developed. Apart from computational prediction and microscopic colocalization assays, biochemical and 
biophysical methods are widely used for qualitative and quantitative assessment of protein bindings. 
 I Introduction    
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Targeted approaches which require prior knowledge of the proteins to be tested, such as co-
immunuoprecipitation followed by immunoblotting, far-Western blotting, surface plasmon resonance and 
isothermal titration calorimetry, are generally limited to testing a small number of binding candidates, 
whereas high-throughput techniques, such as protein microarray, phage display and yeast-two hybrid, allow 
fast detection in a multiplexed format and can be expanded to a genome-wide scale. 
Currently, many of the systemic protein-protein interaction networks of pathogens and model organisms 
have been generated using yeast-two hybrid system (Giot et al., 2003; LaCount et al., 2005; Li et al., 2004; 
McCraith et al., 2000; Rain et al., 2001; Rual et al., 2005; Stelzl et al., 2005; Uetz et al., 2006; Uetz et al., 
2000). While these maps of binary interactions have contributed significantly to systems-level understanding 
of the proteomes, some inherent drawbacks of the technique are also noticeable (Parrish et al., 2006). 
Particularly, such a heterologous system requires two foreign proteins to interact in the yeast cell nucleus.  
This is one of the reasons for the significant number of interactions that are non-biologically relevant in the 
yeast-two hybrid data, i.e. the false positive problem (Parrish et al., 2006). Another perhaps under-estimated 
limitation is that the binary nature of yeast-two hybrid renders it not optimal for detecting cooperative 
bindings in protein complexes (Whitty, 2008). Therefore, an approach that allows proteins to interact in their 
native cellular environment and unbiased detection would be an improvement to the methodology. 
I.1.2. Affinity purification and mass spectrometry 
In contrast to targeted methods, a fully exploratory alternative to discover protein interaction partners is 
affinity purification coupled to mass spectrometry (Gingras et al., 2007). Typically, antibodies are used to 
capture the bait protein together with its binding partners from cell lysates, followed by mass spectrometry 
analysis (Fig. I.1). In an unbiased manner, this powerful approach allows identifying multiple protein 
complexes in one single assay. Yet, one of the biggest challenges is to discriminate specific interactions from 
non-specific contaminants that are bound to the same affinity matrix. This problem becomes even more 
pronounced with the ever-increasing sensitivity and speed of modern mass spectrometry instruments. 
 
 I Introduction    
 




Fig. I.1 | General workflow of a typical affinity purification and mass spectrometry experiment for protein complex 
identification. Illustration reproduced from Gingras et al. (2007). 
 
I.1.2.1 Tandem affinity purification 
To circumvent the issue of non-specific bindings, 
one of the early proposed solutions is the tandem 
affinity purification (TAP) strategy (Rigaut et al., 
1999). This strategy was successfully used to map 
the interactome of budding yeast Saccharomyces 
cerevisiae (Gavin et al., 2002). As depicted in Fig. 
I.2, the TAP tagging approach employs multiple 
purification steps. Ideally, the final eluate should 
be clean from background binders. However, this 
stringent purification strategy can only partially 
eliminate background contaminants while 
increasing the risks of losing interactions that are 
biologically relevant but low in binding affinity 
(Vermeulen et al., 2008). Therefore, a newer 




Fig. I.2 | Overview of the tandem affinity purification (TAP) 
tagging approach. The TAP approach employs a tandem 
affinity tag that allows protein complex purification in two 
steps in order to minimize bindings from background 
contaminants. Scheme taken from Puig et al. (2001). 
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I.1.2.2 Affinity purification and quantitative proteomics 
In order to preserve weak interactions while still 
being able to distinguish specific binders from 
background contaminants, single-step low 
stringency affinity purification combined with 
quantitative proteomics is currently the method 
of choice (Paul et al., 2011; Vermeulen et al., 
2008). As shown in Fig. I.3, in this approach, cells 
are metabolically labeled with different stable 
isotopes, typically using SILAC (stable isotope 
labeling by amino acids in cell culture) (Ong et al., 
2002). Following affinity purification, samples are 
combined to minimize technical variations during 
further processing steps. The co-purified proteins 
are not only identified but also quantified by mass 
spectrometry. Importantly, the mass difference 
introduced by different isotope labels makes it 
possible to differentiate proteins originating from 
different cell populations in a complex mixture. 
Furthermore, the quantification step assists in the search for proteins specifically enriched in the experiment 
pull-down in comparison to the negative control. With this information, specific interaction partners can be 
assigned with high confidence while background binders can be identified based on their similar abundances 
in both the experiment and control pull-downs. Of note, although typically not as accurate as labeling 
approaches, label-free quantification has also been successfully employed for quantitative analysis of affinity 
pull-downs (Hubner et al., 2010; Hubner and Mann, 2011; Rinner et al., 2007; Smits et al., 2013). While such 
 
 
Fig. I.3 | Overview of affinity purification with SILAC-based 
quantitative proteomics using an exogenous affinity tag 
approach. Affinity-purified proteins of different SILAC states 
are combined and measured in the same mass spectrometry 
assay. Specific interaction partners can be identified by 
quantitative analysis of enriched bindings to the bait protein. 
LC-MS/MS, liquid chromatography-tandem mass 
spectrometry. 
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a low stringency approach helps to preserve weak interactions, it would also retain more background 
binders. Therefore, a carefully designed negative control is crucial for a successful experiment. 
I.1.3. Negative control strategies 
In order to accurately identify background contaminants among affinity-purified proteins, a properly 
designed control experiment is a vital prerequisite. Depending on the set-up of the experiment, various 
strategies for the control may be applied (Fig. I.4). Generally, the blocked empty bead approach would only 
work if the antibody used for the experiment pull-down has minimal cross-reactivity to undesired antigens, 
which must be carefully tested. Another commonly used approach is antibody isotype control, i.e., to use an 
antibody of the same isotype as that in the experiment pull-down but against an unrelated epitope. The 
assumption for using this strategy is that the non-specific bindings of the isotype control antibody will be the 
same as the experiment antibody except for their different target antigens. However, the two different 




Fig. I.4 | General strategies for the negative control in quantitative affinity purification experiments. 
 
In order to use the same antibody for both pull-downs, such methods as QUICK (quantitative 
immunoprecipitation combined with knockdown), which depletes the endogenous expression of the bait 
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protein in the control, can capture the same profile of non-specific binders as in the experiment pull-down 
(Fig. I.4) (Selbach and Mann, 2006). This control approach, however, is not applicable when the bait protein 
corresponds to an essential gene or when its depletion would lead to a substantial change of the proteome. 
Currently, the tag-only control strategy combined with transient transfection is widely used for cell-based 
quantitative affinity purification experiments (Paul et al., 2011). This approach makes use of well-
characterized antibodies against affinity tags for both the experiment and control pull-downs. Also, transient 
transfection offers the advantage of minimizing background changes between the control and experiment 
cell populations, as compared to potential clonal differences among stably integrated cell lines. 
I.1.4. In vivo protein-protein interactions 
Protein-protein interaction screens using yeast-two hybrid or cell lines have generated interaction networks 
for organisms from simple life forms to humans (Boxem et al., 2008; Ewing et al., 2007; Giot et al., 2003; Li et 
al., 2004; Malovannaya et al., 2011; Rual et al., 2005; Simonis et al., 2009; Stelzl et al., 2005; Uetz et al., 
2000). In spite of the scale of these interaction maps, in vitro studies can only capture a certain fraction of 
the complex interlinked system between proteins of a living organism. For instance, protein expression is 
regulated according to the functional needs of different tissues. In a developing multi-cellular organism, 
protein expression is also dynamically regulated. Thus, some interacting proteins identified through yeast-
two hybrid or cell lines might in fact never be co-expressed in the same cellular compartment within the 
same tissue. Such interactions are not physiologically relevant in vivo. What are equally important are the 
post-translational modifications (PTMs) which can also mediate protein-protein interactions (Li et al., 
2013a). In an in vitro system, these context-dependent modifications may not be correctly reflected as in 
vivo, thus leaving some biologically important interactions undetected. Consequently, the limitations of in 
vitro approaches necessitate further investigation of the complex interplay of proteins in vivo. 
Affinity purification and mass spectrometry has emerged as a powerful approach also for studying 
protein-protein interactions in vivo. Most of the previous studies, including a recent report on Drosophila 
interactome using more than 200 knock-in lines, were performed in a non-quantitative manner, which 
renders it very difficult to correctly assign genuine interactions (Angrand et al., 2006; Bartoi et al., 2010; 
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Cheeseman et al., 2004; Lowe et al., 2014; Rees et al., 2011). A few in vivo studies that employed 
quantitative interaction proteomics however have a limited scale to single bait proteins (Andlauer et al., 
2014; Hanack et al., 2015). In order to effectively map protein-protein interactions in vivo, substantial 
practical and technical challenges remain to be tackled. For instance, antibodies that can efficiently capture 
endogenous protein complexes are not always readily available, especially for non-mammalian model 
organisms. Similarly, in order to take advantage of affinity tags, it would require generating a large collection 
of knock-in transgenic animals. In parallel, due to multiple cell types that are present in a tissue sample, 
proper quantification and control strategies are particularly critical for the correct assignment of specific 
interactions. 
Given the limitations of current methodology, a new approach is needed for generating in vivo protein-
protein interaction networks. The large resource of GFP fusion transgenic lines of C. elegans (both for 
visualization and affinity purification) plus accurate label-free quantification (Cox et al., 2014) provide a 
unique opportunity to develop such a method that is able to accurately identify the endogenous binding 
partners of the bait protein in a living organism. Particularly, the embryos of C. elegans appear to be an 
attractive model system for investigating in vivo protein-protein interactions. In the next section, an 
overview of C. elegans embryogenesis will be presented with a focus on the regulation of P granule dynamics 
during early development. 
 
I.2. P granule biology in a nutshell 
I.2.1. Germline development during early embryogenesis 
The microscopic nematode roundworm of Caenorhabditis elegans is an extensively researched model 
organism for life science. Thanks to its translucent anatomy, highly reproducible pattern of embryonic cell 
divisions and a wide range of genetic toolkits, C. elegans has been heavily used in studies of animal 
development. Among the many branches of developmental biology, one of the most intriguing is the oocyte-
to-embryo transition. Upon fertilization, the fusion of two differentiated gametes (oocyte and sperm, 
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originating from primordial germline stem cells) triggers complex reprogramming to become yet again a 
totipotent zygote which actively divides and eventually develops into a complete organism. The onset of 
early embryogenesis kick-starts a series of rapid and tightly regulated molecular events which drive among 
others the segregation of germline lineage (Robertson and Lin, 2013). 
As shown in Fig. I.5, the entry of a sperm into an 
oocyte lays down the cue for the posterior pole of the 
embryonic axis (Goldstein and Hird, 1996) and initiates 
egg activation (Marcello and Singson, 2010). The newly 
fertilized egg which was initially arrested at meiotic 
prophase then completes the remaining cycle of meosis I 
(Yamamoto et al., 2006). After undergoing two rounds of 
meiotic divisions, the two pronuclei fuse together and the 
resulting nucleus then enters the embryonic mitotic cell 
cycle (Robertson and Lin, 2013). The first mitosis is the 
first asymmetric cell division which splits the zygote (P0) 
into the somatic blastomere (anterior) and the germline 
precursor (P1, posterior). As embryonic cell division 
progresses, the germline blastomere is further segregated 
and remains as a single precursor cell (P1 -> P2 -> P3 -> 
P4) until around 100-cell stage when it divides into Z2 and 
Z3 primordial germ cells (Sulston et al., 1983). At late first 
larval stage, these two Z2 and Z3 progenitor cells start 
proliferating and eventually grow into the two gonad 
arms of germ cells (Updike and Strome, 2010). 
 
 
Fig. I.5 | Segregation of germline lineage during C. 
elegans early embryogenesis. Germline blastomeres 
are shown in red. Reproduced from Robertson and 
Lin (2013). 
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I.2.2. P granule segregation during oocyte-to-embryo transition 
Germ plasm is the region of maternally derived cytoplasm present in the oocyte which during 
embryogenesis is inherited by only some cells of the embryo and will direct these cells to the germ cell fate 
(Wylie, 2000). Germ plasm has been discovered in multiple animal species. In C. elegans, suspected germ 
plasm was first described as electron-light cytoplasmic areas close to the nucleus of the germline precursor 
cell in early-stage embryos (Krieg et al., 1978). These microscopically visible granular structures were later 
termed P granules after being discovered by fluorescence microscopy using monoclonal antibodies (Strome 
and Wood, 1982, 1983) and under electron microscope (Wolf et al., 1983). Due to its segregation with the 
germline, P granules have traditionally been used as a marker for tracking germ cell lineage throughout C. 
elegans development (Fig. I.6). 
 
 
Fig. I.6 | Diagram of P granule segregation during C. elegans development. P granules, depicted in green, consistently 
segregate with the germline lineage. Reproduced from Updike and Strome (2010).  
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In almost all the gonadal germ cells of C. elegans, P granules show a characteristic peri-nuclear 
localization pattern where they are associated with nuclear pores (Pitt et al., 2000). Exceptions are in the 
maturing oocytes where P granules dissociate from the nuclear envelope and become evenly distributed in 
the cytoplasm as small aggregates (Fig. I.6). P granules are also present in developing spermatocytes but 
become undetectable in mature sperms (Updike and Strome, 2010). In the one-cell embryo, during 
pronuclear migration, P granules start to grow in size and localize towards the posterior pole. By the time of 
pronuclear fusion, the majority of P granules are already portioned into the posterior half of the embryo 
(Hird et al., 1996). Segregation of P granules with the germline lineage continues as embryonic development 
progresses. 
I.2.3. P granule composition and function 
Over 40 proteins have been identified to be P granule components (Table I.1), mainly based on microscopic 
colocalization experiments (Sengupta et al., 2013; Updike and Strome, 2010). While some of these proteins, 
such as GLH-1, GLH-2, PGL-1 and PGL-3, are constitutive components of P granules, others are only 
transiently associated with P granules during the life cycle of a worm (Updike and Strome, 2010). 
Importantly, all P granule components are known to be involved in RNA metabolism and/or possess RNA-
binding domains in their amino acid sequences (Updike and Strome, 2010). Indeed, gonadal P granules have 
been found to contain RNA (Pitt et al., 2000). Embryonic P granules also harbor maternally loaded mRNA 
which is protected from degradation (Seydoux and Fire, 1994). 
Based on its segregation with germ cells and the features of individual components, P granule is thought 
to be involved in germline specification/differentiation and play important roles in post-transcriptional 
regulation in the germline (Pitt et al., 2000; Updike and Strome, 2010). However, the function of P granule 
remains largely unclear. A previous study reported that in the pptr-1 mutant P granules (as shown by GLH 
and PGL proteins) failed to assemble and therefore were not present in the germline blastomeres during 
early embryogenesis, but that the progeny were still fertile (Gallo et al., 2010). This suggests that P granules 
are not required for primordial germ cell determination. However, the segregation of other asymmetrically 
distributed proteins, such as MEX-5 and PIE-1, remained unaltered (Gallo et al., 2010). In another study,  
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Table I.1 | Known C. elegans P granule protein components § 
Protein Description 
CAR-1 Cytokinesis, apoptosis, and RNA-binding 1 TRAL/Lsm14 
CCF-1 CCR4/NOT deadenylase complex 
CDE-1 Uracil nucleotidyltransferase 
CGH-1 Dhh1/DDX6 DEAD-box helicase 
CSR-1 Argonaute required for endo-siRNA 
DCAP-1 mRNA decapping enzyme 
DCAP-2 mRNA decapping enzyme 
DEPS-1 Novel defective P granules and sterile 
DRH-3 Dicer related DEAD-box helicase 
EGO-1 RNA-directed RNA polymerase 
GLD-1 RNA-binding KH domain 
GLD-2 Poly(A) polymerase 
GLD-3 RNA-binding KH domain 
GLD-4 Poly(A) polymerase 
GLH-1 Vasa DEAD-box helicase 
GLH-2 Vasa DEAD-box helicase 
GLH-3 Vasa DEAD-box helicase 
GLH-4 Vasa DEAD-box helicase 
GLS-1 Novel GLD-3/4 interacting protein 
IFE-1 eIF4E mRNA cap-binding 
IFET-1 Translational repressor 
LAF-1 DDX3 DEAD-box helicase 
MEG-1 Novel maternal effect germ cell defective 
MEG-2 Novel maternal effect germ cell defective 
MEX-1 CCCH-type zinc-finger protein 
MEX-3 RNA-binding KH domain 
OMA-1 CCCH-type zinc-finger protein 
OMA-2 CCCH-type zinc-finger protein 
PAB-1 Poly(A)-binding protein 1 
PATR-1 Pat1-decapping cofactor 
PGL-1 Novel RGG domain 
PGL-2 Novel PGL-1 related 
PGL-3 Novel RGG domain 
PIE-1 CCCH-type zinc-finger protein 
POS-1 CCCH-type zinc-finger protein 
PRG-1 Argonaute required for piRNA synthesis 
Sm proteins Splicing factors 
SPN-2 eIF4E-binding protein 
SPN-4 RNP-type RNA-binding domain 
TIA-1 TIA-1 RNP-type RNA-binding domain 
VBH-1 Vasa Belle-like DEAD-box helicase 
WAGO-1 Argonaute required for endo-siRNA 
§ Adapted and summarized from Updike and Strome (2010) and Sengupta et al. (2013).  siRNA, small interfering RNA; 
piRNA, Piwi-interacting RNA. 
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when multiple P granule components were simultaneously depleted, germ cells in the adult gonads lost their 
totipotency and initiated somatic reprogramming, which indicates P granules are essential for maintaining 
the germ cell fate (Updike et al., 2014). These authors proposed a model that P granules selectively degrade 
or compromise the translation of certain soma-promoting transcripts, thereby inhibiting the somatic fate 
and preserving the germ cell identity (Updike et al., 2014). 
I.2.4. Regulation of P granule dynamics during early embryogenesis 
Many genes that influence the formation of P granules have been identified through mutagenesis and RNAi 
studies (Updike and Strome, 2009). During early embryonic development, P granules undergo formation and 
dissolution in a highly dynamic yet tightly controlled manner (Fig. I.7). In the newly fertilized egg which 
remains unpolarized, P granules are evenly distributed as small aggregates. Signals from the sperm-derived 
centrosome trigger polarization and break the symmetry of the one-cell embryo. During polarization, 
posterior PAR proteins (PAR-1, PAR-2, LGL-1) accumulate at the posterior cortex; whereas, the anterior PAR 
proteins (PAR-3, PAR-6, PKC-3) retract from the posterior, consequently leading to two domains of PAR 
proteins in the polarized embryo (Hoege and Hyman, 2013). In parallel, the RNA-binding protein MEX-5 and 
its paralog MEX-6, which were uniformly diffuse in the cytosol before symmetry breaking, start building a 
gradient (high in the anterior, low in the posterior) and eventually become localized only to the anterior half 
(Schubert et al., 2000). As a consequence, P granules begin the localization towards the posterior half 




Fig. I.7 | Asymmetric partition of polarity proteins and P granules during C. elegans early embryogenesis. Adapted 
from Hoege and Hyman (2013). 
 
 I Introduction    
 
20 | P a g e  
 
P granules have been shown to possess liquid-like properties (Brangwynne et al., 2009). Contrary to the 
previous theory that posterior localization of P granules are caused by migration under cytoplasmic flow 
(Cheeks et al., 2004; Hird et al., 1996), Brangwynne and co-authors presented evidence that the flux of P 
granules into the posterior has a similar magnitude to that of the anterior flux, and therefore excluded the 
role of cytoplasmic flow in P granule partioning in the one-cell embryo (Brangwynne et al., 2009). Instead, 
these authors proposed that, after symmetry breaking, the condensation point of soluble P granule proteins 
is lowered in the posterior. As a result, this leads to posterior condensation of components released from 
dissolved anterior P granules, and this process is controlled via the gradient of MEX-5 regulated by 
asymmetric PAR-1 (Brangwynne et al., 2009). A slightly different model was proposed by Gallo et al. (2010), 
in which the regulatory mechanisms are independent for anterior dissolution during interphase (mediated 
by MEX-5) and posterior condensation during mitosis (promoted by PAR-1). They further discovered that 
posterior P granule assembly during mitosis was mediated via pptr-1, functionally downstream of PAR-1 
(Gallo et al., 2010). The protein PPTR-1 is a regulatory subunit of protein phosphatase 2A (PP2A) family. Their 
finding that pptr-1 is required for P granule assembly during mitosis suggests that dephosphorylation by 
PP2A may be important for P granule formation. 
I.2.5. Other key players of anterior P granule disassembly? 
In the one-cell embryo, the anteriorly polarized RNA-binding proteins MEX-5/6 have been repeatedly shown 
to mediate P granule disassembly. Yet, the mechanism how MEX-5 and MEX-6 control granule dissolution 
remains unknown (Nishi et al., 2008). During oocyte-to-embryo transition, asymmetric cell division is also in 
part regulated by selective partitions of maternal proteins (Fig. I.8) (Robertson and Lin, 2013). One of the key 
regulators that assist in this transition is MBK-2. 
The kinase MBK-2 belongs to the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) 
family (Aranda et al., 2011). As shown in Fig. I.8, the activated MBK-2 is initially inhibited and anchored to 
the cell cortex of maturing oocytes by the catalytically inactive pseudophosphatase EGG proteins (Cheng et 
al., 2009). Upon fertilization, cortical MBK-2 is internalized into the cytoplasm of the embryo and appears as 
puncta. This step begins from the anaphase of meiosis I through meiosis II (Pellettieri et al., 2003). Regarding 
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molecular function, MBK-2 has been shown to phosphorylate a subclass of maternal proteins and 
consequently leads to their degradation, including OMA-1, OMA-2 and MEI-1, which are harmful for further 
development following the first embryonic cell division (Nishi and Lin, 2005; Stitzel et al., 2006). MBK-2 also 
phosphorylates MEX-5 and this modification primes MEX-5 for the subsequent phosphorylation by polo 
kinases PLK-1 and PLK-2, which is required for activation of MEX-5 in vivo (Nishi et al., 2008). In addition, 
segregation of some germline proteins, such as PIE-1, MEX-1 and POS-1, is also mediated by protein 
degradation in the somatic blastomeres, which is activated by MEX-5 and MEX-6 (DeRenzo et al., 2003). 
Given the critical importance of MBK-2 in regulating multiple processes during oocyte-to-embryo 
transition, MBK-2 might also directly or indirectly regulate anterior P granule dissolution. Indeed, depletion 
of mbk-2 by RNAi leads to failure in asymmetric segregation of P granules (PGL-1) (Pellettieri et al., 2003). 
This phenotype was observed even in the mildly affected mbk-2(RNAi) embryos where microtubule-related 
 
 
Fig. I.8 | Diagram showing the dynamic localization patterns of some maternal proteins during oocyte-to-embryo 
transition in C. elegans. Reproduced from Robertson and Lin (2013). 
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defects were not present (Pang et al., 2004), suggesting MBK-2 regulates P granule segregation via a 
microtubule-independent mechanism (Pellettieri et al., 2003). Finally, P granule proteins that remain in the 
somatic cells of the embryo have also been found to be degraded in the autophagosomes, mediated via 
cargo proteins SEPA-1 and EPG-2 (Tian et al., 2010; Zhang et al., 2009). 
P granule is arguably the best-studied in vivo model system for ribonucleoprotein (RNP) granules. These 
granules are specific examples of a more general phenomenon of liquid-liquid demixing through phase 
transition. In the next section, a brief summary of known regulatory mechanisms of RNP granule formation 
in other systems will be presented. 
 
I.3. Regulation of ribonulceoprotein granule assembly and 
disassembly in other systems 
Apart from P granules, other types of non-membrane bound compartments exist ubiquitously in the nucleus 
and cytosol of eukaryotic cells (Hyman et al., 2014). Many of these membraneless compartments have been 
shown or predicted to resemble liquid droplets (Brangwynne et al., 2009; Brangwynne et al., 2011; Hyman et 
al., 2014). Examples include nucleoli, Cajal bodies, sites of DNA repair in the nucleus and various cytoplasmic 
RNP granules such as stress granules, processing bodies (P-bodies) and neuronal RNA granules (Hyman et al., 
2014; Kiebler and Bassell, 2006; Weber and Brangwynne, 2012). RNP granules have been found to be 
involved in a wide variety of biological processes, such as RNA metabolism, translational regulation and 
stress response (Kiebler and Bassell, 2006; Weber and Brangwynne, 2012). However, the mechanisms that 
regulate the assembly and disassembly of these RNP granules remain not well understood. 
I.3.1. Biophysical properties of proteins that promote liquid-liquid demixing 
Through phase transition, the demixed liquid compartments allow rapid assembly of soluble components to 
build up high local concentrations and fast exchange with the surrounding pool of other molecules (Hyman 
et al., 2014). Likewise, when no longer required, these dynamic compartments can also be quickly 
dissembled (Hyman et al., 2014). Certain biophysical properties of proteins that promote liquid-liquid 
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demixing have been discovered (Weber and Brangwynne, 2012). Among them is multivalent binding (Li et 
al., 2012). Li and co-authors made use of a trimeric system in which the adaptor protein Nck binds to N-
WASP, and, together with phosphorylated Nephrin, activates actin polymerization (Jones et al., 2006). By 
synthetically generating molecules that harbor multiple SH3 domains of Nck or multiple proline-rich motifs 
(PRM) of its ligand N-WASP, Li et al. demonstrated that these soluble molecules coalesced into liquid 
droplets in solution, depending on the number of the repeated domains. Furthermore, by co-expressing the 
two repeated domains (SH3 and PRM) in living cells, these authors also observed colocalized liquid-like 
puncta, suggesting multivalency could be a general mechanism governing liquid-phase separation (Li et al., 
2012). 
Another amino acid sequence feature that has been shown to drive liquid droplet formation is the low 
compositional complexity region (Han et al., 2012; Kato et al., 2012). In a cell-free system, Kato et al. showed 
that low complexity regions of some RNA-binding proteins could undergo concentration-dependent phase 
transition to form hydrogels. Furthermore, these hydrogels had an amyloid-like structure, but unlike typical 
amyloid aggregation their formation was dynamic and reversible, and they were able to retain the low 
complexity regions of other RNA-binding proteins as well as mRNA (Han et al., 2012; Kato et al., 2012). 
I.3.2. Regulation of RNP granule disassembly by kinase activity 
Primary amino acid sequence features are not the only mechanisms through which liquid-liquid demixing is 
controlled. Given the dynamic nature of RNP granules, control mechanisms that can rapidly regulate granule 
stability in response to cell signaling are expected. Indeed, the dissolution of stress granules, which are 
induced during various types of cellular stress conditions, has been found to require the dual-specificity 
kinase DYRK3 (Wippich et al., 2013). DYRK3 is a mammalian homolog of the C. elegans kinase MBK-2. 
Wippich and co-authors showed that the inactive form of DYRK3 localized to stress granules and prevented 
their dissolution. Upon activation of DYRK3, stress granules dissolved, leading to the release of the 
sequestered mTORC1 from the granules for downstream signal transduction. In addition, activated DYRK3 
also directly phosphorylated the inhibitor protein PRAS40 to allow mTORC1 reactivation, thereby regulating 
the mTOR signaling pathway during stress conditions (Wippich et al., 2013). 
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I.4. Objectives of the thesis 
Studying protein-protein interactions in vivo is arguably 
the most relevant approach to understanding the 
complex interplay of the proteome of an organism 
under a defined biological context. A promising method 
is to combine affinity purification using transgenic GFP 
fusion C. elegans strains with label-free quantitative 
proteomics as displayed in Fig. I.9.  Therefore, the first 
aim of the present thesis is to develop a pipeline that 
allows efficient and quantitative analysis of in vivo 
protein interactions in C. elegans. 
Early embryogenesis is one of the most intriguing 
branches of developmental biology. The smooth 
execution of this complex developmental program 
relies on intricate but tightly controlled regulatory 
mechanisms. In C. elegans, many of key players 
mediating early development have been identified through large-scale RNAi and mutagenesis screens 
(Fernandez et al., 2005; Fraser et al., 2000; Gonczy et al., 2000; Kemphues et al., 1988; Sonnichsen et al., 
2005). To this end, a pilot map of in vivo interactions of essential proteins in early embryos would shed light 
on how these key player proteins coordinate the early stage of development. Such a network would also be 
a potentially important resource for a wider C. elegans research community. 
Germline segregation during asymmetric cell divisions is a critical step in the embryonic development of 
C. elegans. Over the last decades, the association of P granules with the germline has been heavily 
investigated. Yet, many unanswered questions remain to be solved. By functionally following up the 
interaction partners of the bait proteins involved in P granule dynamics, novel regulatory mechanisms might 
 
 
Fig. I.9 | Experimental strategy for affinity purification 
combined with label-free quantitative proteomics to 
identify specific interaction partners in C. elegans early 
embryos. LC-MS/MS, liquid chromatography-tandem 
mass spectrometry. 
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be discovered. These newly identified mechanisms might also help to understand the assembly and 
disassembly of RNP granules in general. 
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II Materials and Methods 
II.1. Chemicals 
Unless stated otherwise, all chemicals were purchased from the following suppliers: Carl Roth (Karlsruhe, 
Germany), Merck (Darmstadt, Germany), Life Technologies (Carlsbad, USA), Sigma-Aldrich (Steinheim, 
Germany). 
 
II.2. Buffers and solutions 
II.2.1. Microbiology culture 
LB (lysogeny broth) medium/agar 
Pre-mixed LB medium/agar powder was purchased from Sigma-Aldrich, dissolved in distilled water, sterilized 
by autoclaving. 
Ampicillin 
100 mg/ml stock solution in distilled water, sterilized by filtration, stored at -20 °C. 
Kanamycin 
50 mg/ml stock solution in distilled water, sterilized by filtration, stored at -20 °C. 
Chloramphenicol 
34 mg/ml stock solution in ethanol, sterilized by filtration, stored at -20 °C. 
Tetracycline 
50 mg/ml stock solution in ethanol, sterilized by filtration, stored at -20 °C. 
II.2.2. DNA sample preparation and electrophoresis 
6× DNA sample loading buffer 
60 mM Tris-HCl pH 8.0, 60% [v/v] glycerol, 0.002% [w/v] bromophenol blue 
TAE (Tris-acetate-EDTA) running buffer 
40 mM Tris-HCl pH 8.5, 40 mM acetic acid, 1 mM ethylenediaminetetraacetic acid (EDTA) 
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II.2.3. SDS-PAGE and Western blotting 
5X SDS (sodium dodecyl sulfate) sample loading buffer 
250 mM Tris-HCl pH7.4, 5mM EDTA, 10% [w/v] SDS, 50% [v/v] glycerol, 0.025% [w/v] bromophenol blue 
MOPS (3-morpholinopropane-1-sulfonic acid) running buffer 
40 ml 20x NuPAGE MOPS running buffer in 760 ml distilled water 
Transfer buffer 
25 mM Tris-HCl pH 8.5, 190 mM glycine, 20% [v/v] methanol in distilled water 
TBST (Tris-buffered saline Tween-20) buffer  
25 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% [v/v] Tween-20 in distilled water 
Blocking solution 
5% [w/v] non-fat milk powder in TBST buffer. 
Stripping buffer (Yeung and Stanley, 2009) 
20 mM Tris-HCl pH7.4, 6 M guanidinium chloride, 0.2% [v/v] NP-40; 0.1 M β-mercaptoethanol freshly added. 
II.2.4. LC-MS sample preparation 
All solutions for LC-MS (liquid chromatography-mass spectrometry) applications were prepared in LC-MS 
grade (LiChrosolv) water or acetonitrile. 
ABC (ammonium bicarbonate) buffer 
50 mM ammonium bicarbonate (NH4HCO3) in water 
Denaturation buffer 
6 M urea, 2 M thiourea in 10 mM HEPES pH 8.0 
Reduction buffer 
10 mM dithiothreitol (DTT) in 50 mM ABC buffer 
Alkylation buffer 
55 mM iodoacetamide in 50 mM ABC buffer 
Buffer A 
5% [v/v] acetonitrile, 0.1% [v/v] formic acid in water 
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Buffer A* 
5% [v/v] acetonitrile, 3% [v/v] trifluoroacetic acid in water 
Buffer B 
80% [v/v] acetonitrile, 0.1% [v/v] formic acid in water 
II.2.5. C. elegans culture and maintenance 
M9 buffer 
22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl, 1mM MgSO4 in distilled water, sterilized by autoclaving. 
Phosphate buffer 
1 M stock solution (0.8 M KH2PO4 , 0.2 M K2HPO4, pH 6.0), sterilized by autoclaving. 
Nematode growth media (NGM) 
Pre-mixed NGM powder was purchased from US Biologicals (Salem, USA), dissolved in distilled water, 
sterilized by autoclaving; when cooled down to 58 °C, phosphate buffer (25 mM), CaCl2 (1 mM) and MgSO4 
(1 mM) were added (to final concentration); aliquots were stored at 4 °C. 
Bleach solution 
NaOCl (available chlorine 1~1.5%), 0.5 M NaOH, 150 mM NaCl in distilled water, freshly prepared. 
II.2.6. C. elegans RNA interference 
IPTG (isopropyl β-D-1-thiogalactopyranoside) 
1 M stock solution in distilled water, sterilized by filtration, stored at -20 °C. 
RNAi feeding agar plates 
50 µg/ml ampicillin, 1 mM IPTG in NGM agar, stored at 4 °C, protected from light exposure. 
II.2.7. C. elegans embryo immunostaining 
PBS (phosphate-buffered saline) buffer 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 in distilled water, pH adjusted to 7.4, sterilized 
by autoclaving. 
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PBST (PBS Tween-20) buffer 
0.05% [v/v] Tween-20 in PBS buffer 
Blocking solution 
0.5% [w/v] bovine serum albumin, 0.5% [w/v] non-fat milk powder in PBST buffer 
 
II.3. Kits and consumables 
Cloning, transformation and DNA purification 
Q5 high-fidelity DNA polymerase for cloning PCR (New England BioLabs, Ipswich, USA) 
Q5 high GC enhancer (New England BioLabs) 
Gateway BP Clonase II Enzyme mix (Life Technologies) 
Gateway LR Clonase II Enzyme mix (Life Technologies) 
Proteinase K solution (2 µg/µl, Life Technologies) 
Mach1 T1 phage-resistant chemically competent E. coli for transformation (Life Technologies) 
SOC medium (super optimal broth with catabolite repression, Life Technologies) 
NucleoBond Xtra Midi plasmid DNA purification kit (MACHEREY-NAGEL, Düren, Germany) 
Invisorb Spin Plasmid Mini Two plasmid DNA purification kit (STRATEC Molecular, Berlin, Germany) 
Invisorb Spin DNA extraction kit (STRATEC Molecular) 
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II.4. C. elegans cultivation 
II.4.1. C. elegans strains 
C. elegans strains were obtained from Caenorhabditis Genetics Center (CGC, University of Minnesota), 
Shohei Mitani (National Bioresource Project for the nematode, Tokyo, Japan), Miyeko Mana/Fabio Piano 
(New York University) and Nikolaus Rajewsky (MDC, Berlin). 
 
II.4.2. C. elegans culture 
C. elegans strains were grown on OP50 E. coli bacteria seeded NGM plates using standard techniques as 
previously described (Brenner, 1974). Worms were maintained at 20°C and transferred to fresh plates twice 
per week. 
Table II.1 | C. elegans strains and mutants used in the present thesis. 
Strain Reference 




pptr-1(tm3103) (Gallo et al., 2010) 
BS1080 ozIs5[GLD-1::GFP::FLAG; unc-119(+)] (Jungkamp et al., 2011) 
EK244 cmIs6[MBK-1::GFP; unc-4(+)] (Raich et al., 2003) 
JH1576 axIs1140[Ppie-1::GFP::MBK-2; unc-119(+)] (Pellettieri et al., 2003) 
JH2015 axIs1462[Ppie-1::GFP::PIE-1::3'pie-1; unc-119(+)] (Merritt et al., 2008) 
JH2017 axIs1464[Ppie-1::GFP::PGL-3::3'pgl-3; unc-119(+)] (Merritt et al., 2008) 
JH2166 axIs1567[Ppie-1::GFP::SPN-4::3'spn-4; unc-119(+)] (Merritt et al., 2008) 
JH2688 axIs1927[Ppie-1::LAP::GLH-1::3'nos-2; unc-119(+)] (Voronina and Seydoux, 2010) 
MG170 (zen-4(or153ts) IV; xsEx6[ZEN-4::GFP]) (Kaitna et al., 2000) 
PF633 nnIs265[Ppie-1::PAR-6::GFP::3'pie-1; unc-119(+)]  
PF720 nnIs352[Ppie-1::POS-1::GFP::3'pie-1; unc-119(+)]  
PF1207 nnIs795[Pgld-1::GEI-12::GFP::3xFLAG::3'unc-54; unc-119(+)]  
SS747 bnIs1[Ppie-1::GFP::PGL-1; unc-119(+)] (Cheeks et al., 2004) 
TH120 ([Ppie-1::GFP::PAR-2::3'par-2]; [Ppie-1::mCherry::PAR-6::3'pie-1]) (Schonegg et al., 2007) 
WH346 ojIs34[GFP::CAR-1; unc-119(+)]  
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II.4.3. SILAC worm culture 
SILAC worm culture was performed as reported (Stoeckius et al., 2014). Briefly, peptone-free NGM plates 
containing 1X antibiotic-antimycotic (Life Technologies) were seeded with concentrated culture of a lysine-
auxotrophic E. coli strain AT713 (CGSC: 4529, Coli Genetic Stock Center, Yale University), which was 
metabolically labeled with either Lys-0: L-lysine-12C614N2 (“light”) or Lys-8: L-lysine-13C615N2 (“heavy”) in 
chemically defined minimal media. Synchronized L1 larvae were added to the seeded plates and grown for 
one generation. Larvae-to-food (number of larvae versus milliliters of SILAC bacterial culture before being 
concentrated) ratio was 200:1. An excess of food was maintained during the entire period of cultivation. 
 
II.5. Mammalian standard and SILAC cell culture 
HEK293T cells (ATCC, Manassas, USA) were maintained in a humidified incubator under 5% CO2 at 37°C in 
DMEM medium (4.5 g/l glucose) supplemented with 10% fetal bovine serum (PAA Laboratories, Cölbe, 
Germany) and 4 mM GlutaMAX (Life Technologies). Cells were passaged twice per week. 
SILAC cell culture was performed using SILAC DMEM media (4.5 g/l glucose) containing (“light”) Lys-0: L-
lysine-12C614N2, Arg-0: L-arginine-12C614N4, or (“medium”) Lys-4: L-lysine-12C614N22D4, Arg-6: L-arginine-13C614N4,  
or (“heavy”) Lys-8: L-lysine-13C615N2, Arg-10: L-arginine-13C615N4 and supplemented with 10% dialyzed fetal 





Polymerase chain reaction (PCR) was performed using manual hot-start technique (polymerase added at the 
initial denaturation step) in a 50-µl reaction volume containing 1X Q5 reaction buffer, 1 ng of DNA template, 
200 µM (each nucleotide) dNTP mix (New England BioLabs), 0.5 µM forward primer (synthesized by BioTeZ, 
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Berlin), 0.5 µM reverse primer, 0.01 U/µl Q5 high-fidelity DNA polymerase, nuclease-free water and with or 
without 30% Q5 High GC Enhancer. 
The PCR reaction was then carried out using the thermocycling profile as follow: initial denaturation at 
98°C for 5 min; 35 cycles of denaturation at 98°C for 20 s, annealing for 30 s (typically, annealing 
temperature at 60°C for the first 7 cycles and 65°C for the remaining 28 cycles), extension at 72°C for 30-40 s 
per kilo base pairs; final extension step at 72°C for 5 min. 
PCR products were resolved by electrophoresis at constant voltage (100 V) in 1% agarose gel containing 
ethidium bromide in TAE buffer. The gel was exposed to UV transillumination, and the gel band of expected 
size was excised with a clean scalpel, followed by purification of the DNA using a commercial gel extraction 
kit (STRATEC Molecular). 
II.6.2. Gateway recombination reaction 
Gateway BP reaction was performed in a 5-µl reaction volume containing 25 femtomoles of PCR products, 75 
ng of pDONR221 vector, 1 µl of Gateway BP Clonase II Enzyme mix and nuclease-free water. The reaction 
mix was incubated at room temperature overnight. After that, 1 µg of proteinase K was added, followed by 
10-min incubation at 37°C. 
Gateway LR reaction was carried out in a 5-µl reaction volume containing 25 ng of entry clone, 50 ng of 
pDEST destination vector, 1 µl of Gateway LR Clonase II Enzyme mix and nuclease-free water. The reaction 
mix was incubated at room temperature for 2 hr to overnight. Following that, 1 µg of proteinase K was 
added and incubated at 37°C for 10 min. 
II.6.3. Transformation and plasmid DNA purification 
Transformation was performed using a standard heat-shock protocol in Mach1 E. coli competent cells. 
Briefly, 2 µl of Gateway reaction products were added to 50 µl of competent cells and incubated at 4°C for 
30 min. Following heat-shock at 42°C for 30 s and incubation at 4°C for 5 min, 250 µl of pre-warmed SOC 
medium was added and incubated on an orbital shaker at 37°C for 1 hr. The culture was then inoculated 
using a Drigalski spatula onto LB agar plates containing corresponding antibiotics for selection and incubated 
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at 37°C overnight. Afterwards, single colonies were inoculated into liquid LB media with the same selection 
antibiotics and cultivated at 37°C overnight in a shaker incubator. 
Plasmid DNA purification was carried out using commercially supplied kits. Briefly, the overnight liquid 
culture was pelleted by centrifugation at 4°C. The concentrated bacteria were then lysed under alkaline 
conditions, followed by neutralization. The plasmid DNA was purified by anion-exchange resin and eluted in 
nuclease-free water. The concentration and purity of the eluted plasmid DNA were then determined by 
spectrophotometric measurements of absorbance at 230, 260 and 280 nm wavelengths. 
II.6.4. DNA sequencing 
All cloned sequences in plasmid DNA were verified by Sanger sequencing using external services offered by 
Source BioScience (Berlin, Germany). Sequencing trace files were carefully checked for sequencing quality 
and mutations using freely available ApE plasmid editor software. 
II.6.5. Construct generation 
Full-length gei-12 was amplified by PCR from N2 cDNA using the Gateway forward primer 5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCTTGAGTTCCTCAAAACCTTACCCA-3’ and reverse primer 5’-
GGGGACCACTTTGTACAAGAAAGCTGGGTATTGATCTCTGGGTGGGTCAAAAATAG-3’, cloned into the pDONR221 
vector and subcloned into pCFJ150 vector (Zeiser et al., 2011) for microparticle bombardment (performed by 
Desirea Mecenas, New York University) and into a pDEST_EGFP destination vector (gift from Markus 
Landthaler, MDC, Berlin) for mammalian cell expression. Fragments of gei-12 were further cloned from gei-
12 cDNA using Gateway primers (Table II.2). 
For generating the mbk-2 RNAi clone, a 1393-bp genomic fragment of mbk-2 was PCR amplified using 
forward primer: 5’-CGATCACACACATCCTCGTC-3’ and reverse primer: 5’-AACCTCATGATCGGCAAGTC-3’, TA 
cloned into the RNAi feeding vector (L4440) and transformed into HT115 bacteria as described (Fraser et al., 
2000) (performed by Miyeko Mana, New York University). 
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Forward: leading sequence1 + 
(5’ -> 3’) 
Reverse:  leading sequence2 + 
(5’ -> 3’) 
N 2 452 AGTTCCTCAAAACCTTACCCAAGCGG CTTGATCGACAGTGAAGTTTTCTTGGG 
N12 2 303 AGTTCCTCAAAACCTTACCCAAGCGG ACGATCCTGGAAGTTGCTGCTA 
N23 144 452 TTCCCAGTATCCACAGATCAGGAC CTTGATCGACAGTGAAGTTTTCTTGGG 
N1 2 143 AGTTCCTCAAAACCTTACCCAAGCGG TCTTCGTTCATACCAGCTGGAGCTA 
N2 144 303 TTCCCAGTATCCACAGATCAGGAC ACGATCCTGGAAGTTGCTGCTA 
N3 304 452 ACTTACTTCAACACAAATGACGATG CTTGATCGACAGTGAAGTTTTCTTGGG 
C 453 862 CGCCGTGGAAGTTCTCGTAGTGCCTC TTGATCTCTGGGTGGGTCAAAAATAG 
C12 453 733 CGCCGTGGAAGTTCTCGTAGTGCCTC TCTTTCAGGTGACATCCCGTGAAT 
C23 593 862 GAAACAGCTTCAGGAAAGCGAATTGCTC TTGATCTCTGGGTGGGTCAAAAATAG 
15’− GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTG 
25’− GGGG AC CAC TTT GTA CAA GAA AGC TGG GTA TCA 
 
II.7. Cell biology work 
II.7.1. RNAi and sterility assays 
Unless stated otherwise, all RNAi clones were from the Ahringer RNAi library (Fraser et al., 2000). Feeding 
RNAi was performed similar to previously described (Kamath et al., 2001). Individual RNAi clones were 
streaked onto LB agar plates containing 50 µg/ml ampicillin and 50 µg/ml tetracycline and incubated 
overnight at 37°C. Single colony was then picked, and the inoculated RNAi bacterial culture was grown in LB 
media containing 50 µg/ml ampicillin for ~7 hr, followed by IPTG (1 mM) induction for 1 hr. The bacterial 
culture was then seeded onto NGM plates containing 50 µg/ml ampicillin and 1 mM IPTG. Seeded plates 
were let dry, protected from light and incubated at room temperature overnight. Synchronized L1 larvae 
were then added to the seeded plates and were incubated at 25°C for ~48 hr until F1 embryos could be 
harvested for further examinations. 
For trans-generational feeding and sterility assays (performed by Patricia Cipriani, New York University), 
L1 larvae were subjected to gei-12(RNAi) continuously through adulthood on solid medium at 15°C or 25°C; 
multiple L1 progeny were individually transferred to new feeding plates and the process was repeated 
through two filial generations. Adults from each generation were examined individually and scored as sterile 
if no embryos were visible in the uterus. 
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II.7.2. Mammalian cell transfection 
For pull-down experiments, cells were seeded to 15-cm cell culture Petri dishes and grown to 50% 
confluence. Plasmid DNA (15 µg) and 30 µg of linear polyethylenimine (PEI) transfection reagent 
(Polysciences, Warrington, USA) were diluted separately in 1.2 ml of serum-free DMEM media. The two 
solutions were then combined and incubated at room temperature for 30 min. Next, 2.4 ml of serum-free 
DMEM media were added to a final volume of 4.8 ml. Following a wash with PBS, the transfection mix was 
added to cells containing 10.2 ml of normal cell culture DMEM media and incubated at 37°C for 24 hr. 
For fluorescence microscopy, cells were seeded onto sterile round coverslips (diameter: 18 mm) in a 12-
well cell culture plate and grown to 80% confluence. Plasmid DNA (1.6 µg) and Lipofectamine 2000 (4 µl, Life 
Technologies) were diluted separately in 100 µl of serum-free DMEM media. The two solutions were then 
mixed together and incubated at room temperature for 5 min. Next, 800 µl of normal cell cluture DMEM 
media were added to a final volume of 1 ml. Following a wash in PBS, the transfection mix was added to cells 
and incubated at 37°C for 4 hr. Afterwards, transfection was stopped by replacing the transfection mix with 
1 ml of normal DMEM media. The next day, cells were fixed directly without an initial washing step. 
II.7.3. Embryo immunostaining and mammalian cell fixation 
Young gravid hermaphrodites were dissected to release embryos to a drop of water (7 µl) on a square 
coverslip. The coverslip was then attached to a glass slide coated with poly-L-lysine, transferred into liquid 
nitrogen and incubated for at least 10 min. Embryonic cells were exposed by a quick flick of the coverslip 
using a razor blade to “crack” open the eggshell, followed by an immediate transfer to pure methanol for 
fixation at -20°C for 10 min. Next, the slide was transferred to pure acetone and incubated at -20°C for 5 
min. Rehydration was performed in a descending acetone series (90%, 75%, 50% and 30%) at 4°C modified 
from Takeda et al. (2008). Following a wash in PBST for 5 min, 25 µl of blocking solution was added to the 
embryos and incubated in a humidified chamber at room temperature for 1 hr. Afterwards, to stain P 
granule proteins, blocking solution was replaced by 25 µl of monoclonal K76 antibody solution (1:5 dilution 
in blocking solution) and incubated at 4°C overnight (Strome and Wood, 1983). After three washes in PBST, 
25 µl of FITC-conjugated anti-mouse IgG (1:200 in blocking solution, Jackson ImmunoResearch, West Grove, 
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USA) was added and incubated at room temperature in the dark for 1 hr. Following another three washes in 
PBST in the dark, slides were mounted using VECTASHIELD mounting medium with DAPI (Vector 
Laboratories, Burlingame, USA). 
Transfected HEK293T cells grown on coverslips were fixed by 4% paraformaldehyde for 15 min and 
washed twice in PBS. Following that, the fixed cells were stained with DAPI (1 µg/ml in PBS) for 2 min in the 
dark and again washed twice in PBS. Slides were mounted using VECTASHIELD HardSet mounting medium 
(Vector Laboratories). 
II.7.4. Fluorescence microscopy 
Live and fixed embryo fluorescence imaging and time-lapse microscopy were carried out using 40X or 63X 
objectives on a Leica DM RA2 microscope equipped with a Hamamatsu C9100-12 EM-CCD camera. Fixed 
mammalian cell fluorescence images were acquired at 63X with a Zeiss Axio Imager M2 system. Images were 
processed in Volocity (version 6.1.1, PerkinElmer) or ImageJ software (version 1.49g) (Schneider et al., 2012). 
 
II.8. Quantitative proteomics and affinity purification assays 
II.8.1. Benchmark for label-free quantification of whole proteomes 
To assess the accuracy of label-free quantification, two label-free samples were prepared in 6M urea/2 M 
thiourea denaturation buffer: sample 1: 1X MCF-7 (human breast cancer cell line, obtained from Wei Chen, 
MDC, Berlin) whole cell lysates (10 µg), 1X E. coli lysate (5 µg); sample 2: 1X MCF-7 whole cell lysates (10 µg), 
4X E. coli lysate (20 µg). These two samples were digested in-solution and measured in succession by LC-MS. 
II.8.2. Simulation of label-free pull-down experiments 
To simulate the detection of label-free pull-down enrichment in a complex non-specific background, two 
samples of predefined composition were prepared: sample 1: 1X E. coli lysate (0.8 µg), 1X UPS2 human 
standard (0.4 µg, Sigma-Aldrich), recombinant CDC42 (0.2 µg, gift from Florian Paul); sample 2: 1X E. coli 
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lysate (0.8 µg), 4X UPS2 human standard (1.6 µg), recombinant RAC1 (0.2 µg), RHOA (0.1 µg) and GFP (0.4 
µg). These two samples were digested in-solution and measured in succession in triplicate by LC-MS. 
II.8.3. Embryo pull-down assays 
Early embryos were freshly harvested in biological triplicate (~2 million embryos each replicate) by bleaching 
young gravid hermaphrodites and sonicated on ice (cycle: 0.5 s, amplitude: 40-45%, 5 strokes/session, 5 
sessions, interval between sessions: 30 s; UP200S ultrasonic processor (Hielscher Ultrasonics, Teltow, 
Germany)) in lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 10% 
glycerol, protease inhibitor cocktail (Roche, Basel, Switzerland), 0.1% Nonidet P-40 Substitute (Sigma-
Aldrich)). After sonication, Nonidet P-40 Substitute was added up to 1% and the lysates were incubated with 
head over tail rotation for 30 min at 4°C, followed by centrifugation at 20,000 × g for 20 min at 4°C. Cleared 
lysate was then aspirated without disturbing the upper lipid layer and split by half into either the anti-GFP 
agarose beads or the blocked control beads (40-50 µl, ChromoTek, Planegg, Germany). After head over tail 
rotation at 4°C for 60-90 min, the beads were washed once with lysis buffer containing 0.1% Nonidet P-40 
Substitute, followed by two times of washing in either buffer I (25 mM Tris-HCl pH 7.4, 300 mM NaCl, 1 mM 
MgCl2) or buffer II (1 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2) or both. For GFP::MBK-2 pull-downs, 
two separate experiments were performed using different washing conditions. Proteins were eluted by 
orbital shaking in 50 µl of denaturation buffer (6 M urea/2 M thiourea in 10 mM HEPES pH 8.0) at room 
temperature without an ethanol precipitation step. For the MBK-1::GFP pull-down experiments, proteins 
were eluted twice by shaking in 50 µl of 8 M guanidinium chloride at 90 °C, followed by ethanol 
precipitation. 
II.8.4. Pull-downs using SILAC worms to assess post-lysis bindings 
For checking the impact of post-lysis interactions, SILAC-labeled “light” BS1080 (GLD-1::GFP) young adults 
were mixed with “heavy” N2 worms, either before lysis or only at the last washing step before elution (Fig. 
III.9 A). For the samples mixed before the pull-down, lysates were incubated with anti-GFP agarose beads for 
60 min and the bound proteins were eluted in denaturation buffer. For the samples mixed after the pull-
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down, the incubation time was 30 min. Elution was performed three times (100 µl each) in 100 mM glycine-
HCl pH 2.5 and neutralized by adding 10 µl of 1 M Tris-HCl pH 8.0, followed by ethanol precipitation. 
II.8.5. GEI-12 pull-downs in mammalian cells 
For the SILAC pull-down experiments using HEK293T cells, the EGFP::GEI-12 (full-length or fragments) 
expressing cells and the control EGFP-only expressing cells were lysed separately with a Dounce 
homogenizer in lysis buffer (25 mM Tris-HCl pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 5% 
glycerol, protease inhibitor cocktail, 1% Triton X-100). Lysates were cleared by centrifugation (20,000 × g for 
20 min at 4°C) and then incubated with anti-GFP agarose beads at 4°C for 90 min, followed by three 
sequential washes in the following buffers: I (25 mM Tris-HCl, pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM EGTA, 
0.1% Triton X-100), II (25 mM Tris-HCl pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM EGTA), III (1 mM Tris-HCl pH 
7.4, 150 mM KCl, 1 mM MgCl2). Beads of the individual SILAC states were combined before the final wash. 
Proteins were eluted using 8 M guanidinium chloride at 90 °C and precipitated by ethanol. 
To check whether GEI-12 interactions were partially mediated by RNA, another pull-down experiment 
against EGFP::GEI-12 was performed using cell lysates pre-treated with or without nuclease (250 U, Pierce 
Universal Nuclease, Thermo Scientific) for 20 min. 
 
II.9. Ethanol protein precipitation and in-solution digestion 
Protein samples that had been eluted by glycine-HCl or guanidinium chloride were precipitated by ethanol. 
For glycine-HCl eluted samples, an additional 70 µl of 2.5 M sodium acetate (pH 5.0) was added. Sample 
volume was filled up to 2 ml with pure ethanol, followed by addition of 2 µl of Glycoblue (Life Technologies). 
Next, the sample was incubated at 4°C overnight. Afterwards, proteins were pelleted by centrifugation at 
20,000 × g for 60 min at 4°C. Supernatant was carefully decanted, and the protein pellet was air-dried and 
resolubilized in 30 µl of denaturation buffer (6 M urea/2 M thiourea in 10 mM HEPES pH 8.0). 
The protein solution in denaturation buffer was reduced in 10 mM DTT for 40 min and alkylated in 5.5 
mM iodoacetamide in the dark at room temperature for 30 min. After that, protein digestion was started by 
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adding endoproteinase Lys-C (lysyl endopeptidase, Wako, Osaka, Japan) at a protein:enzyme ratio of 50:1, 
followed by 3-hr incubation at room temperature with orbital shaking. Next, the sample was diluted 1:4 with 
50 mM ABC buffer and further digested by adding trypsin (sequence grade, Promega, Madison, USA) at a 
protein:enzyme ratio of 50:1. Of note, the trypsin digestion step was skipped for SILAC worm pull-down 
samples that had been labeled with “heavy” Lys-8 only. The sample was then incubated at room 
temperature with orbital shaking overnight. Afterwards, digestion was terminated by 0.7% [v/v] 
trifluoroacetic acid. 
 
II.10. StageTip purification 
Digested peptides were desalted and concentrated by StageTip (stop and go extraction tip) containing 3 
disks of C18 reverse-phase material (Empore, 3M, Minneapolis, USA) (Rappsilber et al., 2007). Briefly, the 
StageTip was activated by 80 µl of pure methanol followed by a wash using 100 µl of buffer A*. Next, the 
peptide solution was loaded to the StageTip and centrifuged at 2,500 × g, followed by another wash using 
100 µl of buffer A*. The StageTip was then stored at 4°C until elution. For LC-MS measurement, the purified 
peptides were eluted by 60 µl of buffer B to a microtiter plate and dried by vacuum centrifugation to a 
volume of 2~3 µl. Afterwards, 5 µl of buffer A was added to each sample. 
 
II.11. Liquid chromatography tandem mass spectrometry 
Peptide mixtures were separated by reversed phase chromatography using the Eksigent NanoLC Ultra 
system or the EASY-nLC system (Thermo Scientific) on a 20-cm fritless silica microcolumn (inner diameter: 75 
µm) packed in-house using ReproSil-Pur C18-AQ 3-µm resin (Dr. Maisch GmbH, Ammerbuch, Germany). 
Peptides were separated on an 8-50% acetonitrile gradient (Velos: 200 min; Q Exactive: 120 min) with 0.5% 
formic acid at a nanoflow rate of 200 nl/min. Eluting peptides were directly ionized by electrospray 
ionization at 2.2 kV and transferred into an LTQ Orbitrap Velos or a Q Exactive Quadrupole-Orbitrap hybrid 
mass spectrometer (Thermo Scientific). 
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For all pull-down experiments, mass spectrometry was conducted using data-dependent mode with one 
full scan (MS) followed by fragmentation scans (MS/MS) of the 20 most intense ions (Velos) or 10 most 
intense ions (Q Exactive). MS scan was performed in the Orbitrap mass analyzer with the following settings: 
for Velos, m/z (mass-to-charge ratio) range: 300-1,700, resolution: 60,000, target value: 106; for Q Exactive, 
m/z range: 300-1,700 or 375-1,700, resolution: 70,000, target value: 3 × 106, maximum injection time: 120 
ms. MS/MS scan was conducted using the following settings: for Velos, collision-induced dissociation (CID) in 
the linear trap quadrupole (LTQ), target value: 3 × 103, isolation width: (+/-) 2.0 m/z, normalized collision 
energy: 40%, dynamic exclusion time: 60 s, monoisotopic precursor selection enabled, wideband activation 
enabled; for Q Exactive, higher energy collision dissociation (HCD), resolution: 35,000, target value: 5 × 105, 
maximum injection time: 120 ms, isolation window: 4.0 m/z, normalized collision energy: 26%, dynamic 
exclusion time: 30 s. Ions with an unassigned or +1 charge state were rejected for precursor ion isolation. 
For the simulation experiments, mass spectrometry was performed on the Q Exactive instrument with 
the following settings: for peptide separation: 200-min acetonitrile gradient (8-50%); for the MS scan: m/z 
range: 300-1,700, resolution: 70,000, target value: 1 × 106, maximum injection time: 120 ms; for the MS/MS 
scans using HCD: resolution: 17,500, target value: 5 × 105, maximum injection time: 60 ms, isolation window: 
2.0 m/z, normalized collision energy: 26%, dynamic exclusion time: 30 s. 
 
II.12. Mass spectrometry data analysis 
Raw data files were processed by MaxQuant software (version 1.4.1.2) (Cox and Mann, 2008) using the built-
in Andromeda search engine against a target-decoy database containing the forward and reverse sequences: 
for C. elegans pull-down data, WormPep release WS245 and E. coli K-12 MG1655 proteome; for human cells, 
Uniprot human proteome release 201402. By default, sequences of 247 common contaminants, such as 
keratins, were also included in the search. Carbamidomethylation of cysteine was used as fixed modification; 
oxidation of methionine and acetylation of the protein N-terminus were set as variable modifications. 
Trypsin/P specificity (cleave C-terminal to lysine and arginine residues also if a proline follows) was chosen 
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for all data except the SILAC worm data, for which LysC/P specificity was used (cleave C-terminal to lysine 
also if a proline follows). Minimal peptide length of 7 amino acids was required and a maximum of 2 missed 
cleavages were allowed. The “second peptide” option was chosen to decipher co-fragmented MS/MS 
spectra. False discovery rate (FDR) was set to 1% for both peptide and protein identifications. Each protein 
group was required to contain at least one unique peptide. 
For in vivo label-free pull-down experiments, protein quantification was performed using the label-free 
quantification (LFQ) algorithm (Cox et al., 2014). Minimum LFQ ratio count was set to one. Both unique and 
razor peptides were considered for quantification. Retention times were recalibrated using the default 
nonlinear time-rescaling algorithm. The “match between runs” option was chosen for transferring MS/MS 
identifications between LC-MS runs with the maximal retention time window set to 1 min. Only proteins 
quantified in at least two out of the three GFP pull-down replicates were included in the analysis. LFQ 
intensities were log2-transformed, and imputation for missing values was performed in Perseus software 
(version 1.2.0.17) (Cox and Mann, 2012) based on a simulated normal distribution to represent low 
abundance values below the noise level (width = 0.3; shift = 1.8). The LFQ abundance ratio was then 
calculated for each protein between the GFP pull-downs and the controls. Significance of the enrichment 
was measured by two-sample Student’s t-test assuming equal variances. Specific interaction partners were 
then determined in a volcano plot where a combined threshold (hyperbolic curve) was set based on a 
modified t-statistic (s0 = 1.5, t0 = 0.9 ~ 1.1) (Li, 2012; Tusher et al., 2001). Threshold values were chosen to 
balance sensitivity and false discovery rate based on the simulation experiment with spike-in standards (Fig. 
III.2). Proteins cross-reactive to the anti-GFP beads were identified by a pull-down assay using wild-type N2 
embryos (Fig. III.6). These proteins as well as HDA-3, a protein identified in almost all other pull-downs, have 
been filtered out. 
For SILAC experiments, maximum of 3 labeled amino acids per peptide were allowed. “Requantify” 
option was chosen. For label-swap SILAC pull-downs, only proteins quantified in both forward and reverse 
experiments were considered for analysis with a minimum SILAC ratio count set to one. For other SILAC pull-
down experiments, a minimum SILAC ratio count of two was required. 
 II Materials and Methods    
 
42 | P a g e  
 
II.13. SDS-PAGE and Western blotting 
Protein samples were reduced and denatured at 90°C for 5 min in SDS sample loading buffer containing 100 
mM DTT. Afterwards, proteins were resolved at constant voltage (100 V) in a NuPAGE precast 4-12% 
gradient gel (Life Technologies) and transferred to a PVDF blotting membrane (Millipore, Billerica, USA ) for 2 
hr at constant current (250 mA) in a tank transfer system. Blocking was done in 5% non-fat milk in TBST 
buffer for 1 hr, followed by primary antibody incubation at 4°C overnight. Primary antibodies were diluted in 
blocking solution as: 1:500 anti-CAR-1 (Boag et al., 2005), 1:500 anti-IFET-1 (Sengupta et al., 2013) and 1:250 
anti-SPN-4 (Huang et al., 2002). After three washes (5 min each) in TBST, the membrane was incubated with 
species-specific horseradish peroxidase-conjugated secondary antibodies (1:10,000, Sigma-Aldrich) at room 
temperature for 1 hr, followed by another three washes in TBST.  The membrane was then briefly incubated 
with substrates for enhanced chemiluminescence (Pierce ECL Plus). Signal was detected by a GE Typhoon 
FLA 9000 biomolecular imager at 473 nm excitation wave-length with an LPB filter. 
 
II.14. Statistical and network analyses 
Statistical and network analyses were performed using R (version 3.1.2), Bioconductor and Cytoscape 
(version 3.1.1). Gene ontology (GO) enrichment analysis for the CAR-1 interactome was conducted using the 
GOstats package (Falcon and Gentleman, 2007). Other enrichment analyses were done based on the 
hypergeometric distribution. RNAi and GO annotations were retrieved from WormBase release WS245. 
Known RNP granule proteins were retrieved from Kato et al. (2012) and converted from mouse to human 
orthologs using the HomoloGene database (Coordinators, 2015). 
For comparison analysis with IVI (in vivo interactome), homomeric interactions and interaction pairs 
containing “dead” genes, which are no longer valid gene model entries in WS245, were removed from the 
WI8 (Worm Interactome version 8) and LCI (literature-curated interaction) datasets (Simonis et al., 2009). 
Different alternative splicing isoforms of the same gene were collapsed into one. For enrichment analyses, 
control gene sets were generated by selecting 3,000 pairs of protein-coding genes at random from WormPep 
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(WS245). The mean percentage of gene pairs with shared RNAi phenotypes or GO terms across 100 
iterations of independent control sets was then used for comparison with the IVI, WI8 and LCI interactome 
datasets. 
Protein disorderness prediction was performed using the IUPred algorithm (Dosztanyi et al., 2005). 
Prediction of binding regions within the disordered parts of a protein was carried out using the ANCHOR 
algorithm (Dosztanyi et al., 2009). The EMBOSS software suite (Rice et al., 2000) was used to calculate 
protein charge distribution, summarized as mean charges of a sliding window of 10 amino acids along the 
length of the protein. 
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III Results 
III.1. In vivo interaction proteomics method development 
III.1.1. Technical assessment and optimization of label-free quantification 
III.1.1.1 Benchmark of whole proteome label-free quantification 
Mass spectrometry is not inherently quantitative (Aebersold and Mann, 2003). Detected peptides are used 
to infer the identity and quantity of the proteins from which they are derived. However, the ion signals of 
peptides detected by a mass spectrometer are not direct measurements of the absolute abundances of the 
proteins present in the original sample.  This is due to various reasons, such as unequal ionization efficiencies 
of different peptides, under-sampling of the instrument, loss of proteins and peptides during sample 
processing procedures. For relative quantification of multiple samples, stable isotope-based methods using 
either metabolic labeling or in vitro chemical-labeling have become standard practice in the last decade. 
Stable isotope labeling has the advantage that it allows different samples to be combined for the same LC-
MS measurement. Since the labeled and unlabeled peptides are identical in chemical composition, they have 
nearly equal chromatographic behaviors while remaining distinguishable by the mass spectrometer due to 
the mass difference. 
Although generally considered not as accurate as labeling-based approaches, label-free quantification 
remains a widely used option. This is mainly due to its simplicity in sample preparation procedures and the 
unrestricted number of samples that can be compared, particularly when primary tissues are studied. Over 
the years, a number of different quantification algorithms have been proposed, from simple spectral 
counting, such as protein abundance index (PAI) and exponentially modified PAI (emPAI) (Ishihama et al., 
2005; Rappsilber et al., 2002), to extracted ion chromatogram (XIC)-based approaches, which integrate 
peptide ion intensities over its chromatographic profile. As expected, XIC-based methods were 
demonstrated to out-perform spectral counting approaches with regard to the accuracy of quantification 
(Ahrne et al., 2013; Grossmann et al., 2010). 
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Recently, the label-free quantification (LFQ) algorithm implemented in the MaxQuant software, has 
been shown to be an accurate and robust approach for quantifying relative protein abundances (Cox et al., 
2014). To benchmark the quantification accuracy of the LFQ algorithm, two label-free samples were 
prepared: both samples contained equal amounts of MCF-7 (human breast cancer cell line) whole cell 
lysates; sample 2 contained four times the amount of E. coli lysates relative to sample 1. These two samples 
were measured in succession using both the Velos and Q Exactive Orbitrap instruments. As depicted in Fig. 
III.1, the two protein populations (human vs. E. coli) were well separated by approximately a log2 fold change 
of 2, corresponding to the 4-fold difference in the relative abundance of E. coli proteins. However, 
quantification accuracy declined as the LFQ intensity became lower, displaying a Christmas tree-like 
distribution which is typically observed in mass spectrometry-based protein quantification (Cox and Mann, 
2008), suggesting that performing multiple replicate experiments may help further improve the accuracy 




Fig. III.1 | Benchmark of whole proteome label-free quantification. Two label-free samples measured in succession by 
a Velos or a Q Exactive Orbitrap mass spectrometer. LFQ, label-free quantification. 
Sample 1: 1X human MCF-7 cell lysate, 1X E. coli lysate; 
Sample 2: 1X human MCF-7 cell lysate, 4X E. coli lysate. 
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III.1.1.2 Simulation of label-free pull-down assays 
In affinity purification of protein complexes coupled with quantitative mass spectrometry, the distinction 
between specific interactions and non-specific background binders relies on quantitative information of 
enriched proteins compared to the negative control (Vermeulen et al., 2008). Modern mass spectrometers 
are fast and highly sensitive. Nowadays, it is common to detect at least hundreds of non-specific 
contaminants binding to the solid matrix in a single pull-down assay. Lately, a report of nearly 200 pull-down 
experiments identified half of the yeast proteome as background binders (Keilhauer et al., 2015). Therefore, 
to detect a small number of enriched proteins in a complex background mixture remains a challenging task. 
In recent years, pull-down assays employing multiple biological replicates, label-free quantification and 
robust statistics have been demonstrated to be an effective approach for detecting specific protein-protein 
interactions with high confidence, both in cell lines and animal tissues (Andlauer et al., 2014; Hanack et al., 
2015; Hubner et al., 2010; Hubner and Mann, 2011). 
 
 
Fig. III.2 | Simulation of label-free pull-down experiments. To simulate the detection of label-free pull-down 
enrichment in a complex non-specific background, two predefined samples were measured in succession in triplicate. 
Sample 1: 1X E. coli lysate, 1X UPS2 human standard, recombinant CDC42; Sample 2: 1X E. coli lysate, 4X UPS2 human 
standard, recombinant RAC1, RHOA and GFP. A combined threshold (hyperbolic curves) was set based on a modified t-
statistic (s0 = 1.5, t0 = 0.8) (Li, 2012; Tusher et al., 2001). 
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To simulate pull-down assays in identifying specifically enriched proteins among a complex background 
mixture and to assess the accuracy of label-free quantification in such an experimental set-up, two samples 
with predefined protein composition were prepared. These two label-free samples contained the same 
amount of E. coli whole cell lysates (to simulate background binders). In addition, both samples contained a 
mixture of 48 different isolated or recombinant human proteins (UPS2 standard) in a 1:4 ratio. Finally, four 
additional recombinant proteins were exclusively spiked-into one of the two samples (Sample 1: CDC42; 
Sample 2: RAC1, RHOA and GFP). These two samples were measured in succession in triplicate by LC-MS. As 
displayed in Fig. III.2, 29 out of 32 detected differential binders were correctly identified. In parallel, 1174 
out of 1184 background binders (E. coli) were also correctly classified. Thus, this benchmark simulation assay 
had a total accuracy of 98.9% and precision of 90.6%, indicating very high accuracy of the method in 
distinguishing enriched binders from background contaminants. 
III.1.2. Optimization of specificity threshold 
III.1.2.1 Definition of the combined cut-off value (hyperbolic curve) 
In spite of the quantitative information, drawing a cut-off line to differentiate between specific and non-
specific binders is not trivial. With multiple experimental replicates and statistics checking consistency of the 
enrichment, both the size (the log fold change) and the statistical significance of the enrichment can be 
assessed in a single volcano plot. This has been well-established practice for large-scale datasets involving 
multiple replicates, such as microarray data. Typically, two empirical thresholds of fixed values are drawn, as 
indicated by two crossed lines perpendicular to each other. However, instead of two arbitrary “hard” cut-
offs, a widely adopted alternative is to use the SAM (statistical analysis of microarray) algorithm developed 
by Tusher et al. (2001). 
The standard Student’s t-statistic is defined as 
[Eq1] 
𝑡 =  
log2 𝐹𝐶
𝑠
,𝑤ℎ𝑒𝑟𝑒 𝑠 𝑖𝑠 𝑡ℎ𝑒 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑒𝑟𝑟𝑜𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑤𝑜 𝑚𝑒𝑎𝑛𝑠. 
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The core of the SAM algorithm is essentially a modified Student’s t-statistic (tSAM). The only difference 
compared to a standard t-statistic (t) is the small penalty value (s0) added to the denominator to stabilize the 
coefficient of variation across the range of intensities. Effectively, the tSAM value is a signal-to-noise ratio with 
a corrected noise level (Li, 2012; Tusher et al., 2001). 
[Eq2] 
𝑡𝑆𝐴𝑀  =  
log2 𝐹𝐶
𝑠 +  𝑠0
 
This allows for defining only a single threshold value of minimum tSAM as t0 to take both the levels of signal 
(enrichment) and noise (variation) into account (Li, 2012). 
[Eq3] 
𝑡𝑆𝐴𝑀  =  
log2 𝐹𝐶
𝑠 +  𝑠0
 ≥ 𝑡0 
When equal variances are assumed, the degree of freedom for a two-sample t-test is fixed, and therefore, 
there will be a one-to-one correspondence between t and the p value (Li, 2012). Accordingly, s can be 
substituted by 
[Eq4] 




and the tSAM equation [Eq3] can then be transformed into 
[Eq5] 
− log10(𝑝 𝑣𝑎𝑙𝑢𝑒)  ∝ 𝑡 =
|log2 𝐹𝐶| × 𝑡0 
|log2 𝐹𝐶| – 𝑠0 × 𝑡0
,𝑤ℎ𝑒𝑟𝑒 |log2 𝐹𝐶|  >  𝑠0 × 𝑡0;  𝑒𝑞𝑢𝑎𝑙 𝑣𝑎𝑟𝑖𝑒𝑛𝑐𝑒𝑠 𝑎𝑠𝑠𝑢𝑚𝑒𝑑. 
This is the equation for the combined cut-off (hyperbolic curve) that is defined by a single threshold value of 
t0, where the curve approaches s0 × t0 on the x-axis of the volcano plot and the corresponding p value of t0 on 
the y-axis, as depicted in Fig. III.3. 
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Fig. III.3 | Diagram of a hypothetical volcano plot for label-free quantitative pull-down assays. The dotted line in grey 
(hyperbolic curve) defines a combined cut-off to distinguish the specific binders (red) from the non-specific background 
contaminants (blue). The green dashed line depicts the limit that the hyperbolic curve approaches: s0 × t0 on the x-axis; 
the corresponding p value of t0 on the y-axis. IP, immunoprecipitation. 
 
III.1.2.2 Optimization of the combined cut-off 
The current thesis employed an empty-bead negative control approach. Thus, theoretically no proteins 
should be specifically enriched in the control pull-down. If any proteins appeared to be enriched on the left 
side of the volcano plot (Fig. III.3), they would be considered false positive hits. In the pull-down simulation 
data (Fig. III.2), since all the E coli. proteins are expected to be categorized as background binders, any 
detected E. coli protein deviated from such is considered a false positive. Therefore, it is possible to calculate 
the true false discovery rate given a certain threshold value (t0). Iteration of this procedure over a range of s0 
and t0 values (varying the hyperbolic curves) showed that the number of false positive hits circumscribed by 
the hyperbolic curve on the left side of the volcano plot is a good estimation of the false positives on the 
right side (Fig. III.4). In other words, in the embryo pull-down samples where the distinction between specific 
and background binders will solely rely on the combined cut-off, minimizing positive hits on the left side of 
the volcano plot would suggest a low false discovery rate in the identified specific interactions. Further 
optimization was assisted by iterative calculation of the sensitivity and false discovery rate of the assay with 
regard to changing thresholds of t0 (Fig. III.5). Taken all together, the determination of the combined cut-off 
 III Results    
 
50 | P a g e  
 
values was based on a balance between sensitivity and false discovery rate, and the following values were 
used for the embryo in vivo protein-protein interaction screen data: s0 = 1.5, t0 = 0.9 ~ 1.1. 
 
 
Fig. III.4 | Optimization of parameters for determining the combined cut-off based on pull-down simulation data. FDR 
on the x-axis represents false positives (E. coli) circumscribed by the hyperbolic curve on the right side of the volcano 
plot. FDR (estimation) on the y-axis represents the number of false positives on the left side of the volcano plot divided 
by the total positive hits on the right side. Iteration over s0 = 0 ~ 20, t0 = 0.1 ~ 2.5, interval = 0.1 for both. FDR, false 
discovery rate. 
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Fig. III.5 | Optimization of parameters for determining the combined cut-off based on pull-down simulation data. FDR 
on the x-axis represents false positives (E. coli) circumscribed by the hyperbolic curve on the right side of the volcano 
plot. Sensitivity (TPR) on the y-axis represents the number of identified true positives divided by the total number of 
detected theoretical differential binders. Iteration over s0 = 0 ~ 20, t0 = 0.1 ~ 2.5, interval = 0.1 for both. FDR, false 
discovery rate; TPR, true positive rate. 
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III.1.3. Minimal cross-reactivity of the anti-GFP antibody 
As already mentioned in the introduction section, the choice of a proper negative control strategy is critical 
for quantitative interaction proteomics. The bead-only control approach removes the use of a control strain 
and thereby completely eliminates any potential biases caused by strain difference or variation in sample 
preparation steps prior to affinity purification. While this approach offers certain advantages, the 
prerequisite is that there should be minimal cross-reactivity of the antibody to any protein other than the 
desired antigen. Pull-down assays using wild-type N2 embryos which did not express GFP showed that the 
single-chain anti-GFP antibody (Rothbauer et al., 2008) used in the present thesis had a very low cross-
reactivity to C. elegans proteins (Fig. III.6). These cross-reactive proteins have also been filtered out from the 
final results of the embryo in vivo protein-protein interaction screen. 
 
 
Fig. III.6 | Volcano plot showing that the background binding profiles of control beads and anti-GFP beads are very 
similar in wild-type N2 worms which do not express GFP fusion proteins. Proteins cross-reactive to the anti-GFP beads 
(highlighted in red) were filtered out from the results of pull-down assays against GFP fusion proteins. 
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III.1.4. CAR-1 interactome in early embryos as proof of concept 
To assess the feasibility of the label-free quantitative pull-down approach to indentify interaction partners in 
C. elegans early embryos, the bait protein CAR-1 was chosen, whose interaction with the RNA helicase CGH-
1 is evolutionarily conserved (Audhya et al., 2005; Boag et al., 2008; Boag et al., 2005), and their interaction 
partners had been well studied (Boag et al., 2008; Boag et al., 2005; Sengupta et al., 2013). CAR-1 
(Cytokinesis, Apoptosis, RNA-associated) is a maternally loaded RNA-binding protein with multiple essential 
functions during germ cell development and embryogenesis. As its gene name indicates, it has been shown 
to be required for early embryonic cytokinesis, inhibit physiologic germ cell apoptosis during oocyte 
development and bind CGH-1 in an RNA-dependent manner (Audhya et al., 2005; Boag et al., 2005). In 
embryos, CAR-1 localizes to cytoplasmic processing bodies (P bodies) as well as P granules (Audhya et al., 
2005; Updike and Strome, 2010). 
In the pull-down assays against GFP::CAR-1, about 2 million transgenic early embryos were harvested 
from young gravid hermaphrodites by bleaching. Three biological replicates were prepared in parallel. For 
each replicate, the same embryo lysates were split by half into anti-GFP pull-down and the control pull-
down. The abundances of the co-purified proteins were assessed by label-free quantitative mass 
spectrometry to identify proteins specifically enriched in the GFP::CAR-1 pull-downs (Fig. III.7 A). A total 
number of 429 proteins were identified in the pull-down assays. Combined with robust statistics as shown in 
a volcano plot (Fig. III.7 B), most of the detected proteins had similar abundances in both the GFP and the 
control pull-downs, indicating they were non-specific background binders. Importantly, the 34 proteins 
significantly enriched in the GFP::CAR-1 pull-downs include the bait proteins, GFP and CAR-1, and almost all 
the proteins (CEY-2, CEY-3, CEY-4, IFET-1, PAB-1) that have been previously found to interact with 
endogenous CAR-1/CGH-1 in vivo, with the exception of ATX-2 and PATR-1 (Boag et al., 2008; Boag et al., 
2005; Sengupta et al., 2013). These results show that the assay targeting GFP fusion protein can efficiently 
identify in vivo interaction partners of the endogenous protein with good sensitivity. 
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Fig. III.7 | Label-free in vivo interaction proteomic strategy and proof-of-concept experiment. (A) Experimental set-up. 
The same extract of early embryos expressing GFP fusion proteins was split and incubated separately with anti-GFP or 
control beads. The abundances of co-purified proteins were measured by mass spectrometry. Three biological 
replicates were performed in parallel. (B) Volcano plot showing specific interaction partners of GFP::CAR-1 based on 
pull-down experiments of three biological triplicates. Interaction partners meeting stringency thresholds (hyperbolic 
curves) are shown in color. Known P granule components among the interaction partners are shown in green. (C) GO 
term enrichment analysis for the interaction partners of GFP::CAR-1. Selected significantly enriched GO terms are 
displayed (conditional hypergeometric test). (D) RNAi phenotype enrichment analysis for the interaction partners of 
GFP::CAR-1. Selected significantly enriched RNAi phenotypes are shown (hypergeometric test). 
 
Among the identified interaction partners, many are known to be at least transiently associated with P 
granules during development (Sengupta et al., 2013; Updike and Strome, 2010). Further gene ontology (GO) 
analyses revealed that “oocyte maturation”, “P granule” and “cytomplasmic mRNA processing body” were  
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among the enriched terms annotated for the 
interaction partners (Fig. III.7 C), consistent with the 
localization of CAR-1 and its known function during 
oogenesis (Boag et al., 2005; Squirrell et al., 2006). In 
parallel, a similar enrichment analysis looking for 
over-represented RNAi phenotypes revealed that 
phenotypes such as “embryonic arrest”, “P granule 
defective”, “cell cleavage variant” and “oocyte 
meiotic maturation variant” were significantly 
enriched in the detected CAR-1 interaction partners 
(Fig. III.7 D). By Western blotting against endogenous 
proteins following the GFP::CAR-1 pull-down, SPN-4 
was confirmed as a novel CAR-1 interaction partner 
(Fig. III.8). Altogether, these results suggest that the 
identified in vivo interactome can reveal important 
biological functions of CAR-1. 
III.1.5. Assessment of in vivo binding using SILAC worm 
To assess the quality of protein-protein interaction screens, it is common practice to validate the results 
either based on known interactions independently reported in the literature or by using a 
secondary/orthogonal method to redemonstrate the detected interactions. However, one question that is 
rarely addressed in reports of protein-protein interactions is whether the identified interaction partners are 
derived from pre-existing endogenous complexes or whether the bindings were formed after cell lysis. This 
question is particularly relevant for protein interaction screen using animal tissues, because homogenization 
breaks down the boundaries of multiple cell and tissue types. As a result, this might lead to bindings formed 




Fig. III.8 | Validation of CAR-1 interaction partners by co-
immunoprecipitation and Western blotting. Three 
examples demonstrating specific binding of GFP::CAR-1 
to CAR-1, IFET-1, and SPN-4 proteins in the experimental 
pull-downs. 
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To address this potential concern, two pull-down experiments were performed using GLD-1::GFP and N2 
young adults mixed at different experimental steps (Fig. III.9 A). The GLD-1::GFP worms were metabolically 
labeled using SILAC as “light” and the wild-type N2 worms as “heavy” (Stoeckius et al., 2014). When the two 
strains are mixed only at the last step of the experiment, the detected “heavy” proteins will only represent 
the level of non-specific background bindings to the beads. In contrast, when the two strains are already 
combined before the lysis step, the detected “heavy” proteins will represent the level of background 
bindings to the beads plus interactions formed in solution. Therefore, a minimal difference between these 
two for a detected interaction partner would indicate minimal post-lysis binding, which would strongly 
suggest that the indentified interaction is derived from pre-existing complexes in vivo. As presented in Fig. 
III.9 B-F, the known interaction partners of GLD-1 (Scheckel et al., 2012) were detected mainly in the “light” 
form with only minute amounts in the “heavy” form. More importantly, with the exception of PAB-1, the 
differences for these proteins between the two experimental set-ups are minimal, indicating they are 
interactions formed in vivo. Collectively, these results show that in vivo interaction proteomics identifies 
binding partners derived primarily from pre-existing protein complexes formed in vivo. 
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III.2. Pilot map of in vivo protein interactome of C. elegans 
early embryogenesis 
III.2.1. Embryo in vivo interactome captures known interactions 
After establishing the quantitative in vivo interaction proteomics method, the present study was extended to 
investigating the interaction partners of eight key player proteins using established C. elegans strains with 
the following features: 1) the GFP fusion protein either rescues the loss-of-function endogenous counterpart 
and/or has a localization pattern consistent with the endogenous protein; 2) they are involved in critical 
developmental processes during early embryogenesis. These bait proteins cover polarity establishment and 
development (MBK-2, PAR-2, PAR-6, ZEN-4) and P granule assembly/regulation (CAR-1, PGL-3, PIE-1). MBK-1, 
as a non-essential paralog of MBK-2, was also included. 
By quantitative analysis of in vivo binding partners of these eight bait proteins in early embryos, a map of 
559 interactions among 472 proteins was generated (Fig. III.10; see Fig. VII.1 and Table VII.1 in the 
supplementary section for an annotated list). This interaction network contains some well-characterized 
interactions that are important during embryogenesis, including the aforementioned conserved complex of 
CAR-1/CGH-1 (Boag et al., 2008), the evolutionarily conserved PAR-3/PAR-6/PKC-3 complex (Suzuki and 
Ohno, 2006), the binding of PAR-6 and LGL-1 (Hoege et al., 2010), the interaction of PAR-2 and PAR-1 (Hoege 
and Hyman, 2013), the centralspindlin motor complex of ZEN-4 and CYK-4 (Mishima et al., 2002), the 
association of PGL-3/SEPA-1/EPG-2, which mediates the autophagic degradation of P granules in somatic 
blastomeres (Tian et al., 2010; Zhang et al., 2009), and the binding of activated MBK-2 to 
pseudophophatases EGG-3 and EGG-4. Besides previously known bindings, this embryo in vivo interactome 
(IVI) network consists mainly of newly identified interactions that are potential targets for further 
investigations. 
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Fig. III.10 | Embryo in vivo interactome (IVI) network. Bait (orange) and prey (pink) proteins are shown as nodes sized 
proportionally to their degree distribution. See Fig. VII.1 and Table VII.1 in the supplementary section for an annotated 
list. 
 
III.2.2. High biological relevance of embryo in vivo interactome 
For multi-cellular organisms, systemic mapping of protein-protein interactions by yeast-two hybrid was first 
performed on C. elegans proteins (Li et al., 2004; Walhout et al., 2000). In fact, due to the lack of a cell line 
system, yeast-two hybrid data remain the primary source of protein-protein interactions reported for C. 
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elegans. The latest release of C. elegans protein interactome WI8 (Worm Interactome version 8) consists of 
interactions assembled from multiple yeast-two hybrid screens (Simonis et al., 2009). Within the same 
report, a collection of low-throughput interaction data curated from literature (LCI, literature curated 
interaction) were also presented (Simonis et al., 2009). The LCI dataset represents hand-picked high-quality 




Fig. III.11 | Stacked bar charts showing the percentages of interacting protein pairs that share at least one annotated 
RNAi phenotype or Biological Process GO term for IVI, WI8 and LCI versus random sets of gene pairs. In the control 
set, percentages are mean values based on 100 random samples of size 3,000 from all protein-coding genes. The color 
scale displays the number of shared annotations between each interacting protein pair. IVI, in vivo interactome; WI8, 
Worm Interactome version 8; LCI, literature-curated interaction. 
 
Protein-protein interaction data provide not only physical and spatial information on complex formation 
but also important hints on functional relationships between binding partners. Since interacting proteins 
often function in the same biological pathway, abolishing the corresponding genes frequently leads to the 
same phenotypic effect (Fraser and Plotkin, 2007; Sonnichsen et al., 2005). The large collection of RNAi 
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phenotype data for C. elegans, therefore, provides an invaluable tool to assess the in vivo functional 
associations between genes. To evaluate the functional relevance of the embryo in vivo interactome (IVI) 
generated in the present thesis, the percentage of two interacting proteins that share the same RNAi 
phenotype(s) was calculated. Indeed, over 50% of all interacting protein pairs from the IVI network share at 
least one RNAi phenotype, more than 10 times higher than what would be expected by random (< 5%) in the 
control (Fig. III.11). When compared with the published yeast-two hybrid WI8 and low-throughput LCI 
datasets, this fraction is on par with the LCI data and considerably higher than the WI8, suggesting the 
embryo IVI data have equal quality as the independently validated interactions for C. elegans (Fig. III.11). 
This is particularly intriguing, since the assignment of an RNAi phenotype to a gene is purely based on 
independent experimental observations without prior knowledge on the association between genes. Similar 
findings were also made for shared gene ontology (GO) terms between interacting protein pairs (Fig. III.11). 
Altogether, these results indicate the high biological relevance of the embryo in vivo interactome data. 
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III.3. MBK-2 and GEI-12 interaction during early embryogenesis 
III.3.1. RNAi screen identified gei-12 as novel regulator of P granule dynamics 
To further explore the value of the embryo in vivo interatome dataset, downstream functional experiments 
were conducted, with a focus on the regulation of P granule dynamics during early embryogenesis. In this 
context, an RNAi perturbation experiment against the identified interaction partners was set up in order to 
experimentally uncover new insights into P granule biology.  
 As already mentioned in the Introduction section of 
this thesis, the DYRK kinase MBK-2 is one of the critical 
regulators of oocyte-to-embryo transition leading to the 
segregation of P granules in the one-cell embryo (Fig. 
III.12) (Pellettieri et al., 2003). However, in the present 
thesis, most of the newly identified interaction partners 
of MBK-2 are not previously known to be involved in P 
granule formation. Therefore, using GFP fusion PGL-1 
and PGL-3 as markers, an RNAi screen against the 
interaction partners of MBK-2 was performed to search 
for phenotypes of P granule defects in early embryos. 
Among a total number of 40 genes individually tested, 
RNAi knock-down of the gene gei-12 exhibited a 
discernible P granule phenotype in the embryos. As 
displayed in Fig. III.13, while P granules segregated 
properly with the P lineage in the controls, depletion of 
gei-12 by RNAi abolished P granule formation (PGL-1 and 
PGL-3) during early embryogenesis. In contrast, P granule assembly in the gonadal germline remained 
unaffected by gei-12(RNAi) (Fig. III.13). In the gei-12(RNAi) embryos, diffuse GFP signal was found in all 
embryonic cells, while in the germline blastomere only minute amounts of discernible granules were 
 
 
Fig. III.12 | Depletion of mbk-2 by RNAi disrupts P 
granule disassembly during early embryogenesis.. 
L4440(RNAi) served as control. 
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observed which disappeared with embryonic cell divisions (Fig. III.13). These observations were also 
confirmed by staining against endogenous P granule proteins using K76 antibodies (Fig. III.14). 
To further assess the impact of gei-12 depletion on P granules, another constitutive component of P 
granules, GLH-1, was chosen as a marker. According to the hierarchy of P granule assembly based on genetic 
studies (Kawasaki et al., 1998; Updike and Strome, 2010), glh-1 acts upstream of pgl-1 and pgl-3 in the 
assembly chain. Upon depletion of gei-12, a similar assembly defect phenotype was observed for the fusion 
protein GFP::GLH-1 (Fig. III.13). This result suggests that during early embryogenesis gei-12 is upstream of 
glh-1 and pgl-1/3 in the formation of P granules. Interestingly, the localization of MBK-2 to the germline 
blastomere was also sabotaged by gei-12(RNAi), indicating gei-12 is also required for the recruitment of 
MBK-2 to the P granules in early embryos (Fig. III.13). However, further experiments showed that knock-
down of gei-12 by RNAi did not affect the segregation of a few other posteriorly localized proteins (CAR-1, 
PIE-1, POS-1 and SPN-4) to the P lineage (Fig. III.15). In summary, these results suggest that gei-12 is 
indispensible for the germline segregation of a subgroup of P granule proteins, including PGL-1/3, GLH-1 and 
 
 
Fig. III.13 | GEI-12 is a novel protein required for P granule assembly. Depletion of gei-12 by RNAi affected P granule 
assembly specifically during early embryogenesis but not prior to fertilization, as visualized in live embryos harboring 
GFP fusions of several proteins that localize to P granules. L4440(RNAi) served as control. 
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MBK-2, specifically during early embryogenesis, and that gei-12 is not crucial for the asymmetric distribution 
of other P granule components. 
 
 
Fig. III.14 | Depletion of gei-12 by RNAi disrupts P granule formation in N2 early embryos. Knocking down the 
paralogs of gei-12 individually by RNAi in N2 embryos did not impair P granule assembly. Fixed embryos were stained 




Fig. III.15 | Depletion of gei-12 by RNAi does not affect asymmetric localization of some other known P granule 
components (CAR-1, PIE-1, POS-1 and SPN-4) during early embryogenesis. 
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III.3.2. Gei-12 and its paralogs 
Despite appearing to be a C. elegans specific gene with no clear orthologs even within nematoda, gei-12 has 
two known paralogs (C36C9.1 and F52D2.12), all of which are located on the X chromosome with a nearly 
identical exon-intron structure and C36C9.1 being closer to gei-12 regarding sequence similarity (Fig. III.16). 
In order to study the potential roles of these paralogs in P granule formation, mutants with large deletions 
(presumably loss-of-function null mutants) were used to investigate their functional association with gei-12. 
 
 
Fig. III.16 | Gene models of gei-12 and its paralogs C36C9.1 and F52D2.12. Deleted regions of mutant alleles (tm4526, 
tm4259, tm4343) are shown in blue. Regions targeted by individual RNAi clones are shown in the “PCR Assays” 
category. Retrieved and reproduced from Wormbase. 
 
Among these deletion mutants, gei-12(tm4526) leads to a large in-frame deletion while both gei-
12(tm4259) and C36C9.1(tm4343) cause an additional frame-shift (Fig. III.16). Interestingly, by using K76 
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antibody staining, P granules in embryos appeared to be unaffected in individual deletion mutants (Fig. 
III.17). In addition, depleting the paralogs C36C9.1 and F52D2.12 individually by RNAi in wild-type N2 worms 
also did not lead to a P granule assembly defect (Fig. III.14). Together with the observation of a P granule 
phenotype in gei-12(RNAi) embryos (Fig. III.14), these results suggest that there is a certain degree of 
functional redundancy among GEI-12 and its paralogs and that the gei-12 RNAi clone (sjj_F52D2.4) can 
efficiently knock down multiple paralogs. Importantly, the sequence regions that can be potentially targeted 
by this particular RNAi clone are indeed highly similar among gei-12 and its paralogs. Moreover, when 
combined with RNAi knock-down of C36C9.1, both gei-12 mutants displayed a P granule defect with a higher 
penetrance than RNAi depletion of gei-12 in wild-type background. 
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III.3.3.  GEI-12 segregates with the germline in C. elegans 
 To further understand the physiologic functions and localization of 
GEI-12 in C. elegans, a GFP fusion GEI-12 knock-in strain was 
generated. Consistent with the aforementioned roles on P granule 
assembly, the distribution of GEI-12 throughout development 
matches the typical localization pattern of a P granule component. 
As depicted in Fig. III.18, GEI-12 localizes to developing germ cells 
with a characteristic peri-nuclear pattern and segregates with the 
P lineage during embryogenesis. Thus, GEI-12 is a maternally-
loaded germline factor which regulates P granule assembly during 
embryonic development. 
III.3.4. Evidence for role of GEI-12 
phosphorylation in P granule dynamics 
The data presented above identified GEI-12 as a critical protein 
required for P granule assembly. However, the mechanism how 
GEI-12 is involved in this process is unclear. The protein appears to 
be worm-specific with no clear orthologs in other species. Due to 
this lack of sequence homology and annotated domains, it is 
difficult to speculate about its functions. A striking feature of the 
GEI-12 sequence is the high percentage (19.4%) of serine/threonine residues (Fig. III.19). The fact that GEI-12 
was identified to be an MBK-2 kinase interaction partner makes it tempting to speculate that MBK-2 
phosphorylates GEI-12 on some of these serine/thronine residues. For DYRK2/3 kinases, the mammalian 
homologs of MBK-2, the phosphorylation consensus sequences (RX2-3S/TP) have been well characterized by 
in vitro experiments (Campbell and Proud, 2002). Replacement of the N-terminal arginine (RX2-3S/TP) by a 
lysine residue (KX2-3S/TP) abolishes the phosphorylation activity by DYRK2/3 (Campbell and Proud, 2002), 
although such a replacement by a similar basic amino acid residue is tolerated for phosphorylation site 
 
 
Fig. III.18 | GEI-12 displays a typical P 
granule localization pattern in C. elegans, 
segregating with the germline and the P 
lineage throughout development. 
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recognition by some basophilic serine/threonine protein kinases (Pinna and Ruzzene, 1996). When this N-
terminal arginine restriction is loosened to K/RX2-3S/TP, GEI-12 indeed contains one putative motif (residues: 
KATKS(582)P) matched to the DYRK2/3 phosphorylation consensus sequences, suggesting that GEI-12 could 
be a potential substrate of MBK-2 kinase. 
Additionally, the P granule assembly 
defect phenotype of gei-12(RNAi) is 
reminiscent of the PP2A phosphatase 
regulatory subunit pptr-1 mutant (Gallo et 
al., 2010), suggesting that GEI-12 could be a 
downstream target of PP2A and potentially 
as its substrate for dephosphorylation. 
Further lines of evidence supporting these 
speculations include: 1) PPTR-2, another 
PP2A regulatory subunit and paralog of 
PPTR-1, was identified as interaction 
partner of MBK-2 in the present study; 2) 
PPTR-2 was previously found to interact 
with GEI-12 by yeast-two hybrid (Simonis et 
al., 2009).  
Collectively, during early embryogenesis, MBK-2 potentially phosphorylates GEI-12 which leads to 
disassembly of P granule in the anterior half of the embryo, whereas PP2A potentially dephosphorylates GEI-
12 and consequently promotes P granule assembly in the posterior. If this extrapolation were true, depleting 
mbk-2 might be able to rescue the P granule assembly defect of the pptr-1 mutant. To test if this is really the 
case, RNAi was used to knock down mbk-2 in the pptr-1 defective mutant. Indeed, loss of mbk-2 could 
restore P granule formation in pptr-1 mutant embryos (Fig. III.20), indicating a counteracting relation 
between mbk-2 and pptr-1 over P granule assembly during early embryogenesis. It needs to be mentioned  
 
 
Fig. III.19 | GEI-12 protein sequence analysis. Serine/threonine 
residues (19.4%) shown in green; predicted low complexity regions 
highlighted in magenta. Prediction was performed using the SEG 
algorithm with default parameters (Wootton and Federhen, 1996). 
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that there remains a lack of direct evidence in the 
present thesis to demonstrate that GEI-12 is 
phosphorylated by MBK-2 and dephosphorylated by 
PP2A in vivo, due to unavailability of antibody against 
GEI-12 and the gei-12::gfp transgene being quickly 
silenced for expression in vivo. Unfortunately, extensive 
efforts to generate a stably integrated GEI-12::GFP 
worm line without silencing for further biochemistry 






III.3.5. GEI-12 is required for germline maintenance 
Sterility assay performed by Patricia Cipriani, New York University. 
Simultaneous depletion of multiple P granule components has been shown to result in sterility after more 
than one generation of RNAi treatment (Updike et al., 2014). Likewise, when L1 larvae were treated with gei-
12 RNAi, they remained fertile upon reaching adulthood; however, further application of gei-12 RNAi to the 
progeny lead to about 5% sterility in the F1 generation and ~20% in the F2 generation at 15°C, and these 
percentages rose to ~25% and ~35% when the assay was carried out at 25°C (Fig. III.21 A). In the 
hermaphrodites, the sterile worms showed hollow uteri and limited germline proliferation with no gametes 
(also in males; Fig. III.21 B and C). In summary, GEI-12 is a key germline factor that is also needed for the 
proliferation of germline, and this requirement becomes greater with temperature. A previous study 
reached a similar conclusion for the P granule components MEG-1 and MEG-2 (Leacock and Reinke, 2008).  
 
 
Fig. III.20 | Depletion of mbk-2 by RNAi restores P 
granule formation in pptr-1 mutant embryos. P 
granules do not segregate normally to the posterior 
due to loss of cell polarity upon mbk-2 depletion. 
L4440(RNAi) served as control. Experiment performed 
by Patricia Cipriani, New York University. 
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Fig. III.21 | GEI-12 is required for germline proliferation and gamete formation. (A) Protocol for continuous 
generational RNAi of gei-12 by feeding. Average sterility rates among adult progeny in first (F1) and second (F2) filial 
generations, with standard error. Adults from the P0 generation were not sterile; sterility among adult progeny 
increased with generation and temperature. (B-C) Examples of adult hermaphrodite (B) and male (C) progeny after 
generational gei-12(RNAi) treatment. Light micrographs (left) and GFP::PGL-1 (right) show reduced germlines with 
fewer PGL-1 positive cells in both sexes. Sterile hermaphrodites also show empty uteri devoid of embryos. Bottom 
panels in (B) show magnified view of highlighted boxes in upper panels. In (C), bracket spans region of defective male 
germline. 
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III.4. GEI-12 granule formation in mammalian cells 
III.4.1. Analysis of full-length GEI-12 protein 
The findings of GEI-12 and its relationships with MBK-2 and PP2A pose an interesting question on whether 
phosphorylation/dephosphorylation is a general mechanism regulating RNP granule formation. Based on 
sequence feature analysis, GEI-12 contains no previously known functional domains other than several low 
complexity regions (Fig. III.19). Also, by using the IUPred algorithm (Dosztanyi et al., 2005), GEI-12 is 
predicted to be highly disordered along most parts of the entire protein, especially in its N-terminal region 
(Fig. III.22). 
Many disordered proteins are believed to be able to adopt various conformations upon binding to 
proteins with a stable structure (Meszaros et al., 2009). According to the ANCHOR algorithm (Meszaros et 
al., 2009), which predicts the regions of a protein capable of a transformation from being disordered to 
ordered upon binding to a globular domain, most parts of the disordered sequences of GEI-12 are predicted 
to be binding regions to structured proteins (Fig. III.23). This prediction result suggests that GEI-12 could 




Fig. III.22 | Disorder prediction of GEI-12 by IUPred algorithm. Prediction type: “long disorder”. Dotted line indicates 
the threshold value of 0.5, above which suggests disordered/unstructured regions. 
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Fig. III.23 | Binding region prediction within the disordered parts of GEI-12 by ANCHOR algorithm. The upper panel: 
probabilities calculated by ANCHOR (blue) are superimposed on the IUPred disorder probabilities (red); the threshold 
probability value is 0.5. The lower panel: long blue vertical bars indicate binding regions; short vertical bars/rectangles 
are regions filtered out by the algorithm. 
 
When expressed in HEK293T cells fused to an N-terminal EGFP, GEI-12 formed granular structures of 
various sizes in the cytosol (Fig. III.24 A). This is intriguing since there are no known homologs of GEI-12 in 
mammals. To further understand these granules, a SILAC-based pull-down experiment against EGFP::GEI-12 
was performed to identify the proteins binding to GEI-12 (Fig. III.24 B). Among its ~300 specific interaction 
partners, over two-thirds turned out to be known RNA-binding proteins, including FXR-1/2, Staufen, 
translation initiation factors and ribosomal proteins, suggesting that these GEI-12 enriched granular 
structures in mammalian cells are RNP granules. This is consistent with the role of GEI-12 in C. elegans as 
expected from the composition of P granules. Furthermore, these proteins (~10%) were also significantly 
enriched for previously known components of various types of RNP granules (p value = 6 × 10-21, 
hypergeometric test) (Kato et al., 2012). One particularly interesting discovery among these interaction 
partners is the PP2A phosphatase subunits, including the catalytic subunit (PPP2CA), structural subunits 
(PPP2R1A, PPP2R1B) and, specifically, several regulatory subunit B56 subfamily members (PPP2R5A, 
PPP2R5C, PPP2R5E). Most of the proteins co-purifying with GEI-12 were not affected by nuclease treatment, 
suggesting that they are not RNA dependent (Fig. III.24 C). 
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Fig. III.24 | GEI-12 forms granules in mammalian 
cells and interacts with RNA-binding proteins 
and PP2A. (A) EGFP::GEI-12 full-length expressed 
in HEK293T cells forms granules (top), whereas 
control cells expressing EGFP only do not 
(bottom). DAPI staining shown in blue. (B) Label-
swap SILAC pull-downs of EGFP::GEI-12 in 
HEK293T cells. The majority of interacting 
proteins are annotated with the GO term “RNA 
binding”. Other interactors include known RNP 
granule components and multiple PP2A subunits 
(catalytic subunit, structural subunits, and several 
regulatory subunit B56 subfamily members). (C) 
SILAC pull-down of EGFP::GEI-12 in HEK293T 
lysates comparing with (H) and without (L) 
nuclease pre-treatment. The majority of GEI-12 
interactions remained unaltered upon nuclease 
treatment, suggesting that they are not RNA 
dependent. 
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III.4.2. Behavior of GEI-12 fragments in mammalian cells 
To further understand the biochemical properties of GEI-12, different fragments of the full-length protein 
were cloned into an expression vector containing an N-terminal EGFP. When expressed in HEK293T cells, 
these fragments displayed rather different localization and distribution patterns (Fig. III.25). All fragments 
containing the N1 region (residues 2-143) were exclusively or, for the N-terminal fragment, partially localized 
to the nucleus. Indeed, GEI-12 contains two predicted nuclear localization signal motifs at residues 15-20 
(RRKRGG) and 291-296 (RKKSRG) (Dinkel et al., 2014), which might in part explain the nuclear localization 
patterns. The N-terminal fragment also formed granules in the cytosol which were generally bigger than 




Fig. III.25 | Expression of GEI-12 fragments fused to an N-terminal EGFP in HEK293T cells. Amino acid residue positions 
of GEI-12 fragments are indicated in parentheses (begin − end). 
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Given the very different distribution patterns of the N- and C-terminal parts of GEI-12 expressed in 
mammalian cells, one interesting question is: do they also interact with different types of proteins? Indeed, 
SILAC pull-down experiments against the N-terminus of GEI-12 revealed that the majority of its interaction 
partners were RNA-binding proteins (Fig. III.26 B), suggesting that the N-terminus is required for RNP granule 
formation in the presence of other RNA-binding proteins. Conversely, the C-terminal part of GEI-12 appeared 
 
Fig. III.26 | GEI-12 N-terminus (residues 2-452) 
and C-terminus (residues 453-862) differ in 
morphology and bind to different classes of 
proteins in mammalian cells. (A) EGFP::GEI-12 N-
terminus expressed in HEK293T cells forms 
aggregates in the nucleus and the cytosol (top), 
whereas the C-terminus is uniformly diffuse in 
the cytosol (bottom). DAPI staining shown in 
blue. (B) Triple SILAC pull-down of EGFP::GEI-12 
N-terminus (“heavy”) in HEK293T cells. The 
majority of interacting proteins are annotated 
with the GO term “RNA binding”. (C) Triple SILAC 
pull-down of EGFP::GEI-12 C-terminus 
(“medium”) in HEK293T cells. Many of interacting 
proteins are PP2A subunit proteins, including the 
catalytic subunits, structural subunits and 
regulatory subunits of B56 subfamily members. 
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to bind mainly the PP2A phosphatase subunits including the catalytic & structural subunits and the 
regulatory subunit B56 subfamily members (PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5E), indicating that the C-
terminus of GEI-12 is the docking site for PP2A and/or is the region of GEI-12 regulated by PP2A 
dephosphorylation activity (Fig. III.26 C). Since the disordered regions of GEI-12 are mainly distributed in the 
N-terminal half of GEI-12 (Fig. III.22), whether this is one reason behind the differences in their distribution 
pattern as well as binding partners is an interesting question for further exploration. 
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IV Discussion 
IV.1. In vivo interaction proteomics 
Quantitative in vivo interaction proteomics is an emerging field that allows detection of specific protein 
interactions with high confidence in an organism under a physiologic/near-physiologic context (Andlauer et 
al., 2014; Hanack et al., 2015; Lundby et al., 2014). The simplicity of a label-free approach retains a high 
degree of quantification accuracy while being simpler and cheaper compared to the sometimes prohibitive 
cost of in vivo SILAC labeling of animals (Cox et al., 2014; Hubner et al., 2010; Hubner and Mann, 2011). The 
versatility is enormous, and such an in vivo approach can in principle be extended to studying interactions in 
pathologic conditions, aging, organogenesis, as well as the dynamical changes of interactions during these 
conditions, and so on. In the present thesis, a label-free quantitative in vivo interaction proteomic approach 
was developed for C. elegans embryos. With further optimization, it should be possible to apply the method 
to investigating protein interactions during other developmental stages and to follow the changes of these 
interactions. 
The present method makes use of GFP fusion C. elegans strains which are fortunately already widely 
available for a large collection of proteins. Moreover, a visible tag offers further utilities in downstream 
functional and validation assays. In principle, this method can be applied to any GFP fusion strain. However, 
one should also be aware of the potential limitations of the method. Although it has been demonstrated 
that known endogenous interaction partners can be efficiently captured using the current method with high 
sensitivity, not all the GFP fusion strains available in the research community are fully representative of the 
endogenous counterparts. This could be due to multiple integrations of the transgene, functional deficits of 
the fusion protein especially in non-rescued strains, non-endogenous expression control and so on. To partly 
solve these problems, a recent large collection of GFP-tagged fosmids that allow for endogenous-level 
expression of the fusion protein under cis regulatory control could be very useful (Sarov et al., 2012). 
Another solution could be to take advantage of the genome editing technique using the CRISPR-Cas9 system 
for seamless insertion of an affinity tag next to the endogenous gene location (Hsu et al., 2014; Tzur et al., 
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2013). Such strains should be able to closely mimic the behavior of the endogenous proteins at a physiologic 
level. Nevertheless, an affinity tag as well as its tagging position (N- or C-terminal) could interfere with or 
change the binding preference of the bait protein. Potential artifacts are therefore embedded in the data. 
With regard to the throughput of the method, it is still rather low, and thus extending it efficiently to a 
“genome-wide” scale of bait proteins remains difficult. 
The present thesis also tried to determine if the detected interaction partners were derived from pre-
existing complexes in vivo or from bindings formed post lysis in solution. Using SILAC labeled transgenic and 
wild-type worms plus mixing at different experimental steps, it was demonstrated that the identified 
interactors for one test strain were indeed derived primarily from protein complexes formed in vivo. This 
was an important step to biochemically assess the quality of the pull-down data. However, it could not be 
ruled out that for other fusion proteins there could still be detected interactions formed post lysis. 
Interestingly, this apparently important issue is rarely addressed in published interaction studies. In fact, the 
idea has been used previously to assess the binding dynamics of protein complexes (Mousson et al., 2008). If 
cell lysates of different SILAC states are mixed before affinity purification, the same binding protein of 
different SILAC labels might swap in between the bait proteins. In contrast, combining independent pull-
downs of different SILAC states only at the final step minimizes any potential swap between labels. A 
comparison of these two approaches could reveal the dynamic behaviors of some interactions. In the 
present thesis, looking from a slightly different viewpoint, the very same technique can be applied to 
investigating the extent of post-lysis effect on complex formation in pull-down experiments.  
Although single-step purification and a highly efficient single-chain anti-GFP antibody have been 
employed in the current method, complex integrity may not be completely preserved upon tissue disruption. 
Therefore, a crosslinking step might be helpful to rescue protein complex components that would otherwise 
become dissociated after lysis (Subbotin and Chait, 2014). Furthermore, an interesting technical addition to a 
crosslinking approach could be to utilize photoactivatable amino acids that allow photo-crosslinking in vivo 
and potentially also in living animals (Suchanek et al., 2005). Of note, a recent report demonstrated fast 
production of highly efficient engineered camelid antibodies (Fridy et al., 2014). In particular, their chimeric 
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single-chain antibodies have been shown capable of capturing 90% of the target protein complex in just 10 
minutes. The reduction in sample preparation time would help to preserve weak or transient interactors 
after affinity purification. Recent development in tissue-specific proteomics using non-canonical amino acids 
also offers the possibility to pinpoint one step further the interactions in a specific tissue or cell type of C. 
elegans (Yuet et al., 2015). 
 
IV.2. Embryo in vivo interactome network 
In the present thesis, a pilot C. elegans embryo interactome map was created for 8 bait proteins. Despite the 
relatively small number of bait proteins, a sizable network consisting of 559 interactions among 472 proteins 
was generated. Importantly, this network captures well-characterized interactions known for their critical 
roles during embryonic development. Likewise, comparison with yeast-two hybrid and literature-curated 
interactions indicates high biological relevance of the in vivo interactome data. Although this is not a fully 
automated high-throughput approach as the robotically operated yeast-two hybrid technique, it is not 
unrealistic to expand the screen to a much larger number of bait proteins. Such a bigger network could 
present finer details on the cooperativity of proteins and the modular organization of protein machines 
during embryogenesis. 
Recent development in high-throughput techniques has led to a previously unthinkable magnitude of 
expansion of big data. Although a global or systems view is increasingly appreciated, the overwhelming 
complexity of information from large-scale datasets is often times a daunting challenge to tackle. While 
systems biologists continue to innovate to extract useful information at a non-traditional level, how to move 
on from large-scale screen data to classical functional studies to explore new biology remains a highly tricky 
task. In C. elegans, the high-throughput nature of RNAi perturbation screen offers an in vivo solution for a 
rapid secondary assay for functional follow-ups. Another solution is through computational integration of 
information at multiple levels to achieve, ironically, data reduction (Stroedicke et al., 2015). In the present 
thesis, only potential new regulators of P granules have been investigated in the functional assays. A 
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comparison with some unpublished genetic interaction data yields several highly interesting candidates for 
experimental follow-ups involving other biological processes. The high functional relevance of the current 
dataset plus the demonstrated usefulness in finding new regulator of P granule dynamics during 
embryogenesis indicate that the embryo in vivo interaction data could be a rich resource for the C. elegans 
research community for further exploration. 
 
IV.3. P granule dynamics during C. elegans embryogenesis 
RNP granules are membraneless compartments contributing to post-transcriptional regulation. Cytoplasmic 
RNP granules such as stress granules and processing bodies are involved in RNA metabolism under various 
cellular conditions, thereby modulating gene expression programs according to functional needs of the cell 
(Anderson and Kedersha, 2006; Kedersha et al., 2013). In a similar fashion, components of the 
developmentally regulated P granules in C. elegans have been shown to be involved in gene expression 
control related to the development of the germline lineage (Mello et al., 1996; Tabara et al., 1999; Voronina 
et al., 2011). P granules are believed to be sites of sequestration of certain maternal RNA, regulating their 
stability and expression in response to dynamic developmental cues. Knowing which RNA species undergo 
such expression controls is therefore of great interest to developmental biologists. Perhaps even more 
interesting questions are: how are different RNA species selected to be incorporated into these granules? 
What are the responsible proteins that determine the outcome of this selection? Although not much is 
currently known, one could speculate that certain transcript sequence features, structural motifs or RNA 
modifications might assist in the recognition process (Pagano et al., 2007). 
At the preceding step, the molecular mechanisms governing P granule formation remain elusive. During 
embryogenesis, P granule assembly has been shown to follow a genetic hierarchy: deps-1 -> glh-1 -> pgl-1/3 
-> ife-1 (Updike and Strome, 2010). However, this simple pathway does not capture all the complex 
regulatory mechanisms that have been found involved in the control of P granule dynamics. The anterior-
posterior gradient of RNA-binding protein MEX-5 in the one-cell embryo appears closest to be the direct 
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regulator that controls the asymmetric partition of P granules (Nishi et al., 2008). The current model 
indicates that the anteriorly partitioned MEX-5 promotes dissolution of P granules in the anterior half of the 
embryo and that these dissolved P granule proteins consequently accumulate in the posterior half and 
coalesce into bigger granules (Brangwynne et al., 2009). Interestingly, no study has so far demonstrated how 
MEX-5 biochemically dissolves P granules. With concrete evidence from all the previously published 
perturbation experiments, it is highly unlikely that the gradient of MEX-5 and dissolution of P granules are 
pure coincidence. Indeed, it has been speculated that MEX-5 might be the carrier/scaffold for another 
effector protein, such as the polo kinase PLK-1 or PLK-2, which undertakes the direct task of P granule 
dissolution. Other effector proteins might also be involved. The precise mechanism requires further 
investigations. 
The DYRK kinase MBK-2, regulator of oocyte-to-embryo transition, has been shown to be required for 
asymmetric segregation of P granules during early embryogenesis in the absence of a clear spindle/polarity 
defect, suggesting that MBK-2 mediates anterior P granule dissolution (Pang et al., 2004; Pellettieri et al., 
2003). In contrast, the PP2A phosphatase subunit PPTR-1 is essential for P granule assembly during mitosis in 
the one-cell embryo (Gallo et al., 2010). In the present thesis, it was demonstrated that depletion of mbk-2 
by RNAi rescued the loss of P granule phenotype in the pptr-1 null mutant, suggesting a genetic interaction 
between mbk-2 and pptr-1 in controlling P granule assembly/disassembly during early embryogenesis. 
The protein GEI-12, newly identified in the present thesis, segregates with the P lineage, displays a P 
granule localization pattern and is an in vivo binding partner of MBK-2. Unfortunately, generating a stably 
integrated C. elegans line of GEI-12::GFP fusion was unsuccessful despite extensive efforts. Therefore, an in 
vivo binding assay between GEI-12 and PPTR-1 could not be performed in C. elegans embryos. However, 
pull-down experiments against GEI-12 expressed in mammalian cells clearly showed the interaction between 
GEI-12 and PP2A subunits, including in particular the B56 regulatory subunit subfamily, which are the 
homologs of PPTR-1. Given also the finding that gei-12 appears to be located upstream of glh-1 and pgl-1/3 
in the P granule assembly pathway, all these results suggest that P granule disassembly and assembly 
specifically during early embryogenesis are in part controlled by phosphorylation (MBK-2) and 
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dephosphorylation (PPTR-1), respectively, at the potential targets of GEI-12 and its paralogs. In summary, a 
hypothetical model is proposed as presented in Fig. IV.1: in the one-cell stage embryo after fertilization, 
MBK-2 phosphorylates GEI-12 and as a result leads to disassembly of P granules in the anterior pole of the 
embryo, whereas in the posterior GEI-12 is dephosphorylated by PP2A and consequently promotes P granule 
assembly.  This hypothetical model was independently supported by a very recent report showing that MBK-
2 can phosphorylate recombinant GEI-12 in vitro and that the phosphorylation status of GEI-12 fusion 
protein in vivo is influenced by mbk-2 and pptr-1 (Wang et al., 2014). Of note, whether MBK-2 and PPTR-1 
are the direct effector proteins on the phosphoyrlation status of GEI-12 in vivo is yet to be experimentally 
confirmed. In this context, it is likely that more kinases and phosphatases are involved. Finding the in vivo 




Fig. IV.1 | Hypothetical model of P granule disassembly and assembly controlled via GEI-12 by phosphorylation 
(MBK-2) in the anterior and dephosphorylation (PP2A) in the posterior of the one-cell embryo. 
 
Previous model of P granule formation is based on the discovery that PGL proteins (PGL-1 and PGL-3) are 
able to autonomously induce RNP granule formation both in mammalian cells and ectopically in C. elegans 
somatic cells in the absence of other germline-specific factors, suggesting that PGL proteins can self-
associate and serve as scaffolds for recruitment of other P granule components (Hanazawa et al., 2011). 
Findings in the present thesis support a new model of phosphorylation control of P granule development 
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during early embryogenesis (Fig. IV.1). In this model, GEI-12 acts as the seed protein for initiating P granule 
assembly and the phosphorylation status determines its aggregation property and, in turn, the 
condensation/dissolution of P granules. GEI-12 is a worm-specific protein with no homologs in mammals, 
based on sequence conservation assessment. However, in mammalian cells in the absence of PGL proteins, 
over-expressed GEI-12 can form granules which are enriched for RNA-binding proteins and known RNP 
granule components. This suggests that despite the lack of apparent conservation at the sequence level the 
fundamental biophysical properties required for granule formation are conserved across species during 
evolution. Of note, instead of granule induction, it cannot be excluded that GEI-12 localizes to existing RNP 
granules in mammalian cells. However, given the relatively large size of some of the GEI-12 granules in the 
cytosol (Fig. III.24 A), it is unlikely they were already formed in the absence of GEI-12. A microscopy 
experiment comparing the localization of GEI-12 interaction partners in mammalian cells before and after 
GEI-12 expression would partially address this question. 
Recent studies have repeatedly emphasized the emerging role of low complexity regions in RNP 
granule/hydrogel formation (Kato et al., 2012; Kwon et al., 2013; Wippich et al., 2013). Low complexity 
regions are composed of residues of low compositional complexity ranging from homotypic repeats of single 
amino acids to mosaic clusters of only a few amino acid types (Wootton, 1994). Due to their low content of 
residue information, these regions are by default filtered out in alignment algorithms, such as BLAST. In vitro 
studies have demonstrated that low complexity regions alone are sufficient to form hydrogels and are able 
to retain other RNA-binding proteins (Kato et al., 2012). While this provides evidence to understand the 
basic mechanism of RNP granule formation, the regulatory mechanisms in vivo are likely to be far more 
complex. For instance, in the embryos of lgg-1 mutant where autophagosomal degradation of PGL proteins 
is impaired, ectopic PGL protein granules appeared in the somatic cells from 16-cell stage onwards (Zhang et 
al., 2009). However, inactivation of sepa-1 in these mutant embryos leads to diffuse distribution of the 
ectopic PGL proteins in the somatic cells (Zhang et al., 2009). These results suggest that despite the ability of 
some granule proteins to self-assemble into granule/hydrogel there appear to be a cohort of promoting and 
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suppressing factors of granule formation, whose complex interplay regulates the assembly and disassembly 
of P granules in vivo. 
 
IV.4. RNP granule assembly and disassembly 
The current thesis presents evidence to support a hypothetical model in which the phosphorylation status of 
GEI-12 orchestrates the stability of P granules, thereby regulating their segregation during embryogenesis. 
Dephosphorylated form of GEI-12 appears to favor P granule assembly, based on the previous report that 
PP2A phosphatase regulatory subunit PPTR-1 is required for P granule assembly in the one-cell embryo 
(Gallo et al., 2010) and current finding that GEI-12 form granules and binds to PP2A subunit proteins in 
mammalian cells. Furthermore, when expressed in mammalian cells, the C-terminal half of GEI-12, the less 
disordered part of the protein, has a uniformly diffuse distribution in the cytosol but appears to be 
responsible for the binding to PP2A phosphatase subunits, whereas the N-terminal half forms aggregates of 
mainly RNA-binding proteins. With these lines of evidence plus the unusually high fraction of 
serine/threonine residues (19.4%) in the GEI-12 sequence, it is tempting to speculate that dephosphorylated 
GEI-12 nucleates granule formation whose stability is maintained by PP2A phosphatases. Likewise, upon 
phosphorylation by MBK-2 or other kinases which changes the net charge/charge distribution of GEI-12, 
granule structure is destabilized and dissolves as a result. 
Indeed, unphosphorylated GEI-12 appears to be primarily positively charged, which is complementary to 
the negatively charged RNA molecules (Fig. IV.2 A). In a thought experiment, introducing the negatively 
charged phosphate groups to GEI-12 in the extreme case could completely change its charge distribution and 
turn it into a highly negatively charged protein (Fig. IV.2 B). This could then presumably disrupt the 
electrostatic interactions between GEI-12 and RNA, leading to granule dissolution. Given the high number of 
potential phosphorylation sites, it is a challenging task to use classical site-specific mutagenesis to pinpoint 
which one or combination of serine/threonine residues of GEI-12 are critical for granule formation. 
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Alternatively, combining live cell imaging with perturbation experiments using selective phosphatase 
inhibitors might help to understand how PP2A stabilizes these RNP granules. 
 
 
Fig. IV.2 | Charge distribution of wild-type GEI-12 (A) and imaginary “highly phosphorylated” version of GEI-12 (B) 
where all serine/threonine residues have been mutated to glutamic acid to mimic phosphorylation. Displayed are the 
mean charges of a sliding window of 10 amino acids along the length of the protein. 
 
RNP granules are known to resemble physical gels where the polymeric matrix is held by weak non-
covalent forces (Hyman et al., 2014). This suggests that a scaffold of interlinked structure with a certain 
degree of orderliness might be present in the granules, whose stability could be affected by factors such as 
temperature, ionic strength and post-translational modifications (Kwon et al., 2013; Nott et al., 2015). Due 
to the important role of phosphorylation in regulating signal transduction, recent studies have highlighted 
the relationship between phosphorylation and hydrogel/granule formation (Kwon et al., 2013; Wippich et 
al., 2013). This is a significant step for understanding how cells regulate the dynamics of membrane-free 
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compartmentalization. Wippich and co-authors found that the kinase activity of DYRK3 is required for 
cytoplasmic stress granule dissolution. Another study demonstrated that the self-polymerized low 
complexity region of the RNA-binding protein FUS functioned as transcriptional activation domain, and that 
the FUS hydrogel could trap the disordered C-terminal region of RNA polymerase II large subunit in its 
unphosphorylated form but not when it was phosphorylated (Kwon et al., 2013). These results led to their 
proposed mechanistic model how phosphorylation regulates the recruitment and release of RNA polymerase 
II to and from actively transcribed genes (Kwon et al., 2013). In summary, these previous findings are 
consistent with the currently proposed model of P granule dynamics controlled by kinase and phosphatase 
interplay. 
Finally, there remain many interesting questions regarding regulation of P granule dynamics. To name a 
few, P granules are liquid-like droplets that can drip and fuse together (Brangwynne et al., 2009). However, 
the emulsion of many small P granules in the cytosol raises an apparent question: what factors prevent these 
granules of close proximity from fusing to become one big aggregate, which is in theory thermodynamically 
favorable, similar to the process of Ostwald ripening (Brangwynne, 2013). Another one is: despite no clear 
gross morphological change, what is the in and out of various transient P granule components contributing 
to the functional role of P granules during development. Answers to many of these questions could reveal 
further details of RNP granule biology which will provide not only the underlying knowledge on normal cell 
physiology but also increasingly the medical implications for understanding and treating human diseases 
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V Conclusions and Outlook 
Studying protein-protein interactions is instrumental in elucidating complex biological processes. In the post-
genomic era, comprehensive mapping of protein-protein interactions provides critical information on the 
mechanical and functional organization of the proteome. Although large-scale interaction networks are 
already available for most model organisms, studying protein-protein interactions in vivo can produce 
arguably the most biologically relevant data. In the present thesis, a new affinity purification approach using 
label-free quantitative interaction proteomics has been developed for investigating in vivo protein-protein 
interactions in C. elegans embryos. Using this method, the first pilot network of in vivo interactions of C. 
elegans embryogenesis was generated. Importantly, this network captures well-characterized known 
complexes and new interactions of high biological relevance. From a technical perspective, one interesting 
extension of the method is to study the dynamics of in vivo protein interactions over a developmental 
timeline. From a biological perspective, this dataset could be a rich resource for future biological follow-up 
studies. Also, expanding the network to a bigger number of bait proteins can deliver more elaborated details 
on the molecular and functional co-operation that regulates early C. elegans development. 
Follow-up studies of the embryo interaction data by RNAi revealed a novel protein, GEI-12, which is an 
essential regulator of P granule dynamics specifically during early embryogenesis. Further functional 
characterization of GEI-12 led to the hypothetical model that MBK-2 kinase and PP2A phosphatase (PPTR-1) 
regulate the phosphorylation status of GEI-12 (and its homologs) and consequently orchestrate the 
formation of P granule during embryogenesis. However, more kinases and phosphatases may be involved in 
controlling GEI-12 phosphorylation. Finding out these potential players will help elucidate this complex 
process. 
Although GEI-12 appears to be worm-specific with no clear homologs in other species, the ability of GEI-
12 to form RNP granules in mammalian cells suggests the fundamental biophysical properties of RNP granule 
formation are conserved over evolution. Therefore, it would be interesting to see if proteins possessing 
similar sequence and functional characteristics of GEI-12 exist also in mammals. The unphosphorylated form 
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of GEI-12 appears to be favorable for granule formation whose stability seems to be maintained by PP2A-
mediated activities. It would be interesting to reconstitute granule assembly using recombinant GEI-12 of 
various phosphorylation states and assess their abilities to form hydrogels in solution as well as the kinetics 
of bindings to other P granule components. In this context, perhaps what may be even more interesting is to 
develop new strategies to modulate RNP granule formation, which might have implications for novel 
therapeutic options in clinical practice. In summary, the fundamental mechanisms governing RNP granule 
assembly and disassembly have just begun to be understood. More research efforts are needed to uncover 
these universal principles that underlie many of the basic biological phenomena. 
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VII Supplementary Information 
VII.1. Abbreviations 
Abbreviation Full name 
A Ampere 
ABC ammonium bicarbonate 
cDNA complementary deoxyribonucleic acid 
CID collision-induced dissociation 
DMEM Dulbecco's Modified Eagle Medium 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
DYRK dual-specificity tyrosine phosphorylation-regulated kinase 
EDTA ethylenediaminetetraacetic acid 
EGFP enhanced green fluorescent protein 
EGTA ethylene glycol tetraacetic acid 
emPAI exponentially modified protein abundance index 
FDR false discovery rate 
GFP green fluorescent protein 
GO gene ontology 
HCD higher energy collision dissociation 
HEK human embryonic kidney 
hr hour 
IP immunoprecipitation 
IPTG isopropyl β-D-1-thiogalactopyranoside 
IVI in vivo interactome 
LB lysogeny broth 
LCI literature-curated interaction  
LC-MS liquid chromatography-mass spectrometry 
LC-MS/MS liquid chromatography-tandem mass spectrometry 
LFQ label-free quantification 
LTQ linear trap quadrupole 
Lys-C lysyl endopeptidase 
min minute 
MOPS 3-morpholinopropane-1-sulfonic acid 
MS mass spectrometry 
ms millisecond 
NGM nematode growth media 
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Abbreviation Full name 
PAI protein abundance index 
PBS phosphate-buffered saline 
PBST phosphate-buffered saline Tween-20 
PCR polymerase chain reaction 
PEI polyethylenimine 
PP2A protein phosphatase 2A 
PRM proline-rich motif 
PTM post-translational modification 
RNA ribonucleic acid 
RNAi RNA interference 
RNP ribonucleoprotein 
s second 
SAM statistical analysis of microarray 
SDS sodium dodecyl sulfate 
SH3 SRC Homology 3 
SILAC stable isotope labeling by amino acids in cell culture 
SOC super optimal broth with catabolite repression 
StageTip stop and go extraction tip 
TAE Tris-acetate-EDTA 
TAP tandem affinity purification 
TBST Tris-buffered saline Tween-20 
TPR true positive rate 
V volt 
WI8 Worm Interactome version 8 
XIC extracted ion chromatogram 
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VII.2. Supplementary figure 
 
 
Fig. VII.1 | Embryo in vivo interactome (IVI) network annotated with protein names. Bait (orange) and prey (pink) 
proteins are shown as nodes sized proportionally to their degree distribution. 
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VII.3. Supplementary table 
Table VII.1 | Complete list of embryo in vivo interactome data 
Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
Y18D10A.17 WBGene00012484 car-1 D1022.7 WBGene00000101 aka-1 
Y18D10A.17 WBGene00012484 car-1 F46F11.2 WBGene00000473 cey-2 
Y18D10A.17 WBGene00012484 car-1 M01E11.5 WBGene00000474 cey-3 
Y18D10A.17 WBGene00012484 car-1 Y39A1C.3 WBGene00000475 cey-4 
Y18D10A.17 WBGene00012484 car-1 C07H6.5 WBGene00000479 cgh-1 
Y18D10A.17 WBGene00012484 car-1 B0348.6 WBGene00002061 ife-3 
Y18D10A.17 WBGene00012484 car-1 Y71H2AM.19 WBGene00002244 laf-1 
Y18D10A.17 WBGene00012484 car-1 Y62E10A.12 WBGene00003077 lsm-3 
Y18D10A.17 WBGene00012484 car-1 W03C9.7 WBGene00003228 mex-1 
Y18D10A.17 WBGene00012484 car-1 F53G12.5 WBGene00003229 mex-3 
Y18D10A.17 WBGene00012484 car-1 W02A2.7 WBGene00003230 mex-5 
Y18D10A.17 WBGene00012484 car-1 C49H3.5 WBGene00003827 ntl-4 
Y18D10A.17 WBGene00012484 car-1 C09G9.6 WBGene00003864 oma-1 
Y18D10A.17 WBGene00012484 car-1 ZC513.6 WBGene00003865 oma-2 
Y18D10A.17 WBGene00012484 car-1 Y106G6H.2 WBGene00003902 pab-1 
Y18D10A.17 WBGene00012484 car-1 F45E4.2 WBGene00004046 plp-1 
Y18D10A.17 WBGene00012484 car-1 F52E1.1 WBGene00004078 pos-1 
Y18D10A.17 WBGene00012484 car-1 F56F3.1 WBGene00004132 ifet-1 
Y18D10A.17 WBGene00012484 car-1 ZC404.8 WBGene00004984 spn-4 
Y18D10A.17 WBGene00012484 car-1 Y92C3B.2 WBGene00006697 uaf-1 
Y18D10A.17 WBGene00012484 car-1 Y116A8C.35 WBGene00006698 uaf-2 
Y18D10A.17 WBGene00012484 car-1 F53H2.3 WBGene00010006 F53H2.3 
Y18D10A.17 WBGene00012484 car-1 F54D5.5 WBGene00010051 F54D5.5 
Y18D10A.17 WBGene00012484 car-1 R05D11.8 WBGene00011036 edc-3 
Y18D10A.17 WBGene00012484 car-1 T12G3.6 WBGene00011741 T12G3.6 
Y18D10A.17 WBGene00012484 car-1 C03G5.1 WBGene00015391 sdha-1 
Y18D10A.17 WBGene00012484 car-1 C06G1.4 WBGene00015547 ain-1 
Y18D10A.17 WBGene00012484 car-1 C42D4.1 WBGene00016594 C42D4.1 
Y18D10A.17 WBGene00012484 car-1 F26B1.2 WBGene00017816 F26B1.2 
Y18D10A.17 WBGene00012484 car-1 F44E2.8 WBGene00018421 F44E2.8 
Y18D10A.17 WBGene00012484 car-1 PAR2.1 WBGene00019800 mtss-1 
Y18D10A.17 WBGene00012484 car-1 T19B4.5 WBGene00020558 T19B4.5 
Y18D10A.17 WBGene00012484 car-1 Y53G8AR.9 WBGene00021816 Y53G8AR.9 
T04C10.1 WBGene00003149 mbk-1 K07C11.2 WBGene00000098 air-1 
T04C10.1 WBGene00003149 mbk-1 K04G2.8 WBGene00000156 apr-1 
T04C10.1 WBGene00003149 mbk-1 T20B5.1 WBGene00000161 apa-2 
T04C10.1 WBGene00003149 mbk-1 K08F8.2 WBGene00000220 atf-2 
T04C10.1 WBGene00003149 mbk-1 R10E11.1 WBGene00000366 cbp-1 
T04C10.1 WBGene00003149 mbk-1 C17G10.4 WBGene00000383 cdc-14 
T04C10.1 WBGene00003149 mbk-1 C48D1.2 WBGene00000417 ced-3 
T04C10.1 WBGene00003149 mbk-1 R107.6 WBGene00000549 cls-2 
T04C10.1 WBGene00003149 mbk-1 Y108G3AL.1 WBGene00000838 cul-3 
T04C10.1 WBGene00003149 mbk-1 F11H8.4 WBGene00000872 cyk-1 
T04C10.1 WBGene00003149 mbk-1 F43G6.1 WBGene00001016 dna-2 
T04C10.1 WBGene00003149 mbk-1 T23G7.1 WBGene00001061 dpl-1 
T04C10.1 WBGene00003149 mbk-1 Y106G6H.12 WBGene00001112 duo-3 
T04C10.1 WBGene00003149 mbk-1 Y102A5C.18 WBGene00001161 efl-1 
T04C10.1 WBGene00003149 mbk-1 Y48C3A.17 WBGene00001162 efl-2 
T04C10.1 WBGene00003149 mbk-1 F55A8.1 WBGene00001186 egl-18 
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Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
T04C10.1 WBGene00003149 mbk-1 F52D2.4 WBGene00001569 gei-12 
T04C10.1 WBGene00003149 mbk-1 M04B2.3 WBGene00001585 gfl-1 
T04C10.1 WBGene00003149 mbk-1 ZC308.1 WBGene00001596 gld-2 
T04C10.1 WBGene00003149 mbk-1 T07F8.3 WBGene00001597 gld-3 
T04C10.1 WBGene00003149 mbk-1 Y18D10A.5 WBGene00001746 gsk-3 
T04C10.1 WBGene00003149 mbk-1 R12B2.4 WBGene00001869 him-10 
T04C10.1 WBGene00003149 mbk-1 C12C8.1 WBGene00002026 hsp-70 
T04C10.1 WBGene00003149 mbk-1 Y48G1A.5 WBGene00002079 xpo-2 
T04C10.1 WBGene00003149 mbk-1 F44C4.4 WBGene00002148 gon-14 
T04C10.1 WBGene00003149 mbk-1 M01E11.6 WBGene00002225 klp-15 
T04C10.1 WBGene00003149 mbk-1 C41G7.2 WBGene00002226 klp-16 
T04C10.1 WBGene00003149 mbk-1 T19E10.1 WBGene00002297 ect-2 
T04C10.1 WBGene00003149 mbk-1 K08E7.3 WBGene00002368 let-99 
T04C10.1 WBGene00003149 mbk-1 F20H11.2 WBGene00002889 let-765 
T04C10.1 WBGene00003149 mbk-1 ZK637.7 WBGene00002998 lin-9 
T04C10.1 WBGene00003149 mbk-1 C03B8.4 WBGene00003002 lin-13 
T04C10.1 WBGene00003149 mbk-1 F18A1.2 WBGene00003012 lin-26 
T04C10.1 WBGene00003149 mbk-1 C32F10.2 WBGene00003020 lin-35 
T04C10.1 WBGene00003149 mbk-1 C06C3.1 WBGene00003196 mel-11 
T04C10.1 WBGene00003149 mbk-1 W02A2.7 WBGene00003230 mex-5 
T04C10.1 WBGene00003149 mbk-1 T05C12.6 WBGene00003241 mig-5 
T04C10.1 WBGene00003149 mbk-1 F43C1.2 WBGene00003401 mpk-1 
T04C10.1 WBGene00003149 mbk-1 F52G2.1 WBGene00003582 dcap-2 
T04C10.1 WBGene00003149 mbk-1 ZK1290.4 WBGene00003592 nfi-1 
T04C10.1 WBGene00003149 mbk-1 K10C3.6 WBGene00003639 nhr-49 
T04C10.1 WBGene00003149 mbk-1 F54E7.3 WBGene00003918 par-3 
T04C10.1 WBGene00003149 mbk-1 T26E3.3 WBGene00003921 par-6 
T04C10.1 WBGene00003149 mbk-1 C10F3.5 WBGene00003954 pcm-1 
T04C10.1 WBGene00003149 mbk-1 C07G1.3 WBGene00003961 pct-1 
T04C10.1 WBGene00003149 mbk-1 Y75B8A.30 WBGene00004085 pph-4.1 
T04C10.1 WBGene00003149 mbk-1 C18E9.3 WBGene00004105 szy-20 
T04C10.1 WBGene00003149 mbk-1 D2023.2 WBGene00004258 pyc-1 
T04C10.1 WBGene00003149 mbk-1 F56B6.2 WBGene00004350 rgs-7 
T04C10.1 WBGene00003149 mbk-1 T11F8.3 WBGene00004374 rme-2 
T04C10.1 WBGene00003149 mbk-1 F18E2.3 WBGene00004738 scc-3 
T04C10.1 WBGene00003149 mbk-1 F32H2.3 WBGene00004953 spd-2 
T04C10.1 WBGene00003149 mbk-1 Y56A3A.4 WBGene00006396 taf-12 
T04C10.1 WBGene00003149 mbk-1 T24F1.1 WBGene00006414 raga-1 
T04C10.1 WBGene00003149 mbk-1 F23B12.6 WBGene00006465 fntb-1 
T04C10.1 WBGene00003149 mbk-1 F58A4.8 WBGene00006540 tbg-1 
T04C10.1 WBGene00003149 mbk-1 W02A11.4 WBGene00006700 uba-2 
T04C10.1 WBGene00003149 mbk-1 Y54E10A.9 WBGene00006888 vbh-1 
T04C10.1 WBGene00003149 mbk-1 Y111B2A.22 WBGene00007027 ssl-1 
T04C10.1 WBGene00003149 mbk-1 VC5.4 WBGene00007029 mys-1 
T04C10.1 WBGene00003149 mbk-1 Y111B2A.11 WBGene00007030 epc-1 
T04C10.1 WBGene00003149 mbk-1 F41E6.6 WBGene00007055 tag-196 
T04C10.1 WBGene00003149 mbk-1 B0365.1 WBGene00007150 acly-2 
T04C10.1 WBGene00003149 mbk-1 C09F9.2 WBGene00007479 C09F9.2 
T04C10.1 WBGene00003149 mbk-1 C14H10.2 WBGene00007592 C14H10.2 
T04C10.1 WBGene00003149 mbk-1 C17E4.6 WBGene00007645 C17E4.6 
T04C10.1 WBGene00003149 mbk-1 C48G7.3 WBGene00008183 rin-1 
T04C10.1 WBGene00003149 mbk-1 F07A11.2 WBGene00008546 gfat-1 
T04C10.1 WBGene00003149 mbk-1 F16A11.3 WBGene00008878 ppfr-1 
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Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
T04C10.1 WBGene00003149 mbk-1 F26H11.2 WBGene00009180 nurf-1 
T04C10.1 WBGene00003149 mbk-1 F39B2.1 WBGene00009553 F39B2.1 
T04C10.1 WBGene00003149 mbk-1 F52B5.3 WBGene00009922 F52B5.3 
T04C10.1 WBGene00003149 mbk-1 F52D10.2 WBGene00009930 F52D10.2 
T04C10.1 WBGene00003149 mbk-1 F53C11.7 WBGene00009976 swan-2 
T04C10.1 WBGene00003149 mbk-1 F54D5.5 WBGene00010051 F54D5.5 
T04C10.1 WBGene00003149 mbk-1 H38K22.2 WBGene00010428 dcn-1 
T04C10.1 WBGene00003149 mbk-1 K03D10.3 WBGene00010537 mys-2 
T04C10.1 WBGene00003149 mbk-1 K03H4.2 WBGene00010549 K03H4.2 
T04C10.1 WBGene00003149 mbk-1 K05C4.7 WBGene00010583 K05C4.7 
T04C10.1 WBGene00003149 mbk-1 K07G5.6 WBGene00010645 fecl-1 
T04C10.1 WBGene00003149 mbk-1 M04B2.4 WBGene00010847 M04B2.4 
T04C10.1 WBGene00003149 mbk-1 T07D4.4 WBGene00011580 ddx-19 
T04C10.1 WBGene00003149 mbk-1 T09E8.1 WBGene00011647 noca-1 
T04C10.1 WBGene00003149 mbk-1 T14G10.3 WBGene00011773 ttr-53 
T04C10.1 WBGene00003149 mbk-1 W04A4.5 WBGene00012234 W04A4.5 
T04C10.1 WBGene00003149 mbk-1 W08G11.4 WBGene00012348 pptr-1 
T04C10.1 WBGene00003149 mbk-1 Y37D8A.2 WBGene00012544 Y37D8A.2 
T04C10.1 WBGene00003149 mbk-1 Y39A1A.21 WBGene00012658 Y39A1A.21 
T04C10.1 WBGene00003149 mbk-1 Y39B6A.38 WBGene00012696 reps-1 
T04C10.1 WBGene00003149 mbk-1 Y40B1A.4 WBGene00012735 sptf-3 
T04C10.1 WBGene00003149 mbk-1 Y47D3A.28 WBGene00012935 mcm-10 
T04C10.1 WBGene00003149 mbk-1 Y48G10A.2 WBGene00013019 Y48G10A.2 
T04C10.1 WBGene00003149 mbk-1 Y51H1A.4 WBGene00013095 ing-3 
T04C10.1 WBGene00003149 mbk-1 Y59A8B.22 WBGene00013354 snx-6 
T04C10.1 WBGene00003149 mbk-1 Y66D12A.10 WBGene00013436 Y66D12A.10 
T04C10.1 WBGene00003149 mbk-1 Y67H2A.10 WBGene00013465 Y67H2A.10 
T04C10.1 WBGene00003149 mbk-1 ZK1098.4 WBGene00014221 ZK1098.4 
T04C10.1 WBGene00003149 mbk-1 B0303.3 WBGene00015125 B0303.3 
T04C10.1 WBGene00003149 mbk-1 BE0003N10.2 WBGene00015267 chin-1 
T04C10.1 WBGene00003149 mbk-1 C16C8.11 WBGene00015849 C16C8.11 
T04C10.1 WBGene00003149 mbk-1 C17E7.4 WBGene00015899 C17E7.4 
T04C10.1 WBGene00003149 mbk-1 C25B8.4 WBGene00016088 clec-266 
T04C10.1 WBGene00003149 mbk-1 C29E4.2 WBGene00016202 kle-2 
T04C10.1 WBGene00003149 mbk-1 C30H7.2 WBGene00016278 C30H7.2 
T04C10.1 WBGene00003149 mbk-1 C35E7.5 WBGene00016457 C35E7.5 
T04C10.1 WBGene00003149 mbk-1 C35E7.6 WBGene00016458 C35E7.6 
T04C10.1 WBGene00003149 mbk-1 C36C9.1 WBGene00016485 C36C9.1 
T04C10.1 WBGene00003149 mbk-1 C41D11.7 WBGene00016566 eri-7 
T04C10.1 WBGene00003149 mbk-1 F09F7.6 WBGene00017303 F09F7.6 
T04C10.1 WBGene00003149 mbk-1 F17E9.4 WBGene00017541 F17E9.4 
T04C10.1 WBGene00003149 mbk-1 F23H11.1 WBGene00017757 bra-2 
T04C10.1 WBGene00003149 mbk-1 F26F4.5 WBGene00017827 F26F4.5 
T04C10.1 WBGene00003149 mbk-1 F26F4.11 WBGene00017830 rpb-8 
T04C10.1 WBGene00003149 mbk-1 F44E2.2 WBGene00018416 retr-1 
T04C10.1 WBGene00003149 mbk-1 F45E12.1 WBGene00018474 cnep-1 
T04C10.1 WBGene00003149 mbk-1 K09H11.3 WBGene00019600 rga-3 
T04C10.1 WBGene00003149 mbk-1 R09A1.1 WBGene00019971 ergo-1 
T04C10.1 WBGene00003149 mbk-1 R13F6.10 WBGene00020068 cra-1 
T04C10.1 WBGene00003149 mbk-1 T08B2.5 WBGene00020346 T08B2.5 
T04C10.1 WBGene00003149 mbk-1 T08B2.7 WBGene00020347 T08B2.7 
T04C10.1 WBGene00003149 mbk-1 T22D1.10 WBGene00020687 ruvb-2 
T04C10.1 WBGene00003149 mbk-1 W03A5.4 WBGene00020968 W03A5.4 
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Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
T04C10.1 WBGene00003149 mbk-1 W03A5.6 WBGene00020970 W03A5.6 
T04C10.1 WBGene00003149 mbk-1 W05F2.4 WBGene00021036 W05F2.4 
T04C10.1 WBGene00003149 mbk-1 Y39G10AR.8 WBGene00021466 Y39G10AR.8 
T04C10.1 WBGene00003149 mbk-1 Y44E3A.6 WBGene00021551 Y44E3A.6 
T04C10.1 WBGene00003149 mbk-1 Y45G5AM.7 WBGene00021559 Y45G5AM.7 
T04C10.1 WBGene00003149 mbk-1 Y50D4C.5 WBGene00021749 Y50D4C.5 
T04C10.1 WBGene00003149 mbk-1 Y54F10BM.1 WBGene00021856 Y54F10BM.1 
T04C10.1 WBGene00003149 mbk-1 Y55F3AM.1 WBGene00021920 mrps-25 
T04C10.1 WBGene00003149 mbk-1 Y110A7A.8 WBGene00022458 prp-31 
T04C10.1 WBGene00003149 mbk-1 ZK154.5 WBGene00022667 ZK154.5 
T04C10.1 WBGene00003149 mbk-1 ZK1236.3 WBGene00023405 sor-1 
T04C10.1 WBGene00003149 mbk-1 ZK662.4 WBGene00023497 lin-15B 
T04C10.1 WBGene00003149 mbk-1 ZK678.1 WBGene00023498 lin-15A 
T04C10.1 WBGene00003149 mbk-1 F11A10.8 WBGene00044329 cpsf-4 
F49E11.1 WBGene00003150 mbk-2 K07C11.2 WBGene00000098 air-1 
F49E11.1 WBGene00003150 mbk-2 C25A11.4 WBGene00000100 ajm-1 
F49E11.1 WBGene00003150 mbk-2 C36A4.8 WBGene00000264 brc-1 
F49E11.1 WBGene00003150 mbk-2 Y56A3A.20 WBGene00000369 ccf-1 
F49E11.1 WBGene00003150 mbk-2 ZC518.3 WBGene00000376 ccr-4 
F49E11.1 WBGene00003150 mbk-2 F01F1.8 WBGene00000381 cct-6 
F49E11.1 WBGene00003150 mbk-2 F22D3.1 WBGene00000459 ceh-38 
F49E11.1 WBGene00003150 mbk-2 Y54F10AM.4 WBGene00000464 ceh-44 
F49E11.1 WBGene00003150 mbk-2 T25G3.2 WBGene00000496 chs-1 
F49E11.1 WBGene00003150 mbk-2 R107.6 WBGene00000549 cls-2 
F49E11.1 WBGene00003150 mbk-2 Y60A3A.10 WBGene00000987 dhs-24 
F49E11.1 WBGene00003150 mbk-2 C18D1.1 WBGene00000995 die-1 
F49E11.1 WBGene00003150 mbk-2 C25F6.2 WBGene00001006 dlg-1 
F49E11.1 WBGene00003150 mbk-2 F43G6.1 WBGene00001016 dna-2 
F49E11.1 WBGene00003150 mbk-2 T23G7.1 WBGene00001061 dpl-1 
F49E11.1 WBGene00003150 mbk-2 Y102A5C.18 WBGene00001161 efl-1 
F49E11.1 WBGene00003150 mbk-2 Y48C3A.17 WBGene00001162 efl-2 
F49E11.1 WBGene00003150 mbk-2 F55A8.1 WBGene00001186 egl-18 
F49E11.1 WBGene00003150 mbk-2 F52D2.4 WBGene00001569 gei-12 
F49E11.1 WBGene00003150 mbk-2 M04B2.3 WBGene00001585 gfl-1 
F49E11.1 WBGene00003150 mbk-2 ZC308.1 WBGene00001596 gld-2 
F49E11.1 WBGene00003150 mbk-2 T07F8.3 WBGene00001597 gld-3 
F49E11.1 WBGene00003150 mbk-2 Y18D10A.5 WBGene00001746 gsk-3 
F49E11.1 WBGene00003150 mbk-2 ZK381.1 WBGene00001862 him-3 
F49E11.1 WBGene00003150 mbk-2 ZK742.1 WBGene00002078 xpo-1 
F49E11.1 WBGene00003150 mbk-2 F26F12.7 WBGene00002637 let-418 
F49E11.1 WBGene00003150 mbk-2 F57B9.2 WBGene00002845 let-711 
F49E11.1 WBGene00003150 mbk-2 ZK637.7 WBGene00002998 lin-9 
F49E11.1 WBGene00003150 mbk-2 C03B8.4 WBGene00003002 lin-13 
F49E11.1 WBGene00003150 mbk-2 K10B2.1 WBGene00003009 lin-23 
F49E11.1 WBGene00003150 mbk-2 C32F10.2 WBGene00003020 lin-35 
F49E11.1 WBGene00003150 mbk-2 T22A3.3 WBGene00003083 lst-1 
F49E11.1 WBGene00003150 mbk-2 Y69A2AR.30 WBGene00003161 mdf-2 
F49E11.1 WBGene00003150 mbk-2 ZC302.1 WBGene00003405 mre-11 
F49E11.1 WBGene00003150 mbk-2 ZK1127.1 WBGene00003784 nos-2 
F49E11.1 WBGene00003150 mbk-2 C18E3.7 WBGene00004093 ppw-1 
F49E11.1 WBGene00003150 mbk-2 C18E9.3 WBGene00004105 szy-20 
F49E11.1 WBGene00003150 mbk-2 W02D9.1 WBGene00004181 pri-2 
F49E11.1 WBGene00003150 mbk-2 ZK675.1 WBGene00004208 ptc-1 
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Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
F49E11.1 WBGene00003150 mbk-2 F31E3.3 WBGene00004340 rfc-4 
F49E11.1 WBGene00003150 mbk-2 C50E10.4 WBGene00004945 sop-2 
F49E11.1 WBGene00003150 mbk-2 F32A6.5 WBGene00006064 sto-2 
F49E11.1 WBGene00003150 mbk-2 T05H10.5 WBGene00006734 ufd-2 
F49E11.1 WBGene00003150 mbk-2 C06A5.7 WBGene00006823 unc-94 
F49E11.1 WBGene00003150 mbk-2 F44F1.7 WBGene00006902 vet-6 
F49E11.1 WBGene00003150 mbk-2 Y111B2A.22 WBGene00007027 ssl-1 
F49E11.1 WBGene00003150 mbk-2 C13G3.3 WBGene00007554 pptr-2 
F49E11.1 WBGene00003150 mbk-2 C14B1.5 WBGene00007576 dph-1 
F49E11.1 WBGene00003150 mbk-2 C33G3.6 WBGene00007906 C33G3.6 
F49E11.1 WBGene00003150 mbk-2 C39E9.12 WBGene00008035 C39E9.12 
F49E11.1 WBGene00003150 mbk-2 C47E12.4 WBGene00008149 pyp-1 
F49E11.1 WBGene00003150 mbk-2 D2005.5 WBGene00008400 drh-3 
F49E11.1 WBGene00003150 mbk-2 F16A11.3 WBGene00008878 ppfr-1 
F49E11.1 WBGene00003150 mbk-2 F17C11.10 WBGene00008921 F17C11.10 
F49E11.1 WBGene00003150 mbk-2 F26H11.2 WBGene00009180 nurf-1 
F49E11.1 WBGene00003150 mbk-2 F30A10.6 WBGene00009264 sac-1 
F49E11.1 WBGene00003150 mbk-2 F36A2.13 WBGene00009460 F36A2.13 
F49E11.1 WBGene00003150 mbk-2 F44F4.2 WBGene00009701 egg-3 
F49E11.1 WBGene00003150 mbk-2 F54B3.1 WBGene00010013 F54B3.1 
F49E11.1 WBGene00003150 mbk-2 F54B3.3 WBGene00010015 atad-3 
F49E11.1 WBGene00003150 mbk-2 F54D5.5 WBGene00010051 F54D5.5 
F49E11.1 WBGene00003150 mbk-2 H19N07.2 WBGene00010406 math-33 
F49E11.1 WBGene00003150 mbk-2 H37N21.1 WBGene00010427 hpo-11 
F49E11.1 WBGene00003150 mbk-2 K02B9.2 WBGene00010493 meg-2 
F49E11.1 WBGene00003150 mbk-2 K04B12.2 WBGene00010550 K04B12.2 
F49E11.1 WBGene00003150 mbk-2 K04C1.2 WBGene00010552 K04C1.2 
F49E11.1 WBGene00003150 mbk-2 K09B11.9 WBGene00010713 uso-1 
F49E11.1 WBGene00003150 mbk-2 M106.4 WBGene00010912 gmps-1 
F49E11.1 WBGene00003150 mbk-2 R07E5.11 WBGene00011117 R07E5.11 
F49E11.1 WBGene00003150 mbk-2 R07H5.8 WBGene00011128 R07H5.8 
F49E11.1 WBGene00003150 mbk-2 T05F1.2 WBGene00011489 T05F1.2 
F49E11.1 WBGene00003150 mbk-2 T05H10.1 WBGene00011507 T05H10.1 
F49E11.1 WBGene00003150 mbk-2 T08A11.1 WBGene00011604 T08A11.1 
F49E11.1 WBGene00003150 mbk-2 T12G3.1 WBGene00011737 sqst-1 
F49E11.1 WBGene00003150 mbk-2 T24F1.2 WBGene00011994 samp-1 
F49E11.1 WBGene00003150 mbk-2 T28C6.7 WBGene00012121 T28C6.7 
F49E11.1 WBGene00003150 mbk-2 Y47D3A.28 WBGene00012935 mcm-10 
F49E11.1 WBGene00003150 mbk-2 Y57G11C.3 WBGene00013301 Y57G11C.3 
F49E11.1 WBGene00003150 mbk-2 Y105E8A.17 WBGene00013676 ekl-4 
F49E11.1 WBGene00003150 mbk-2 Y106G6D.1 WBGene00013698 Y106G6D.1 
F49E11.1 WBGene00003150 mbk-2 ZK512.5 WBGene00013985 sec-16 
F49E11.1 WBGene00003150 mbk-2 ZK858.3 WBGene00014117 clec-91 
F49E11.1 WBGene00003150 mbk-2 C02F5.4 WBGene00015347 cids-1 
F49E11.1 WBGene00003150 mbk-2 C04E7.2 WBGene00015429 sor-3 
F49E11.1 WBGene00003150 mbk-2 C05C8.9 WBGene00015466 hyls-1 
F49E11.1 WBGene00003150 mbk-2 C06G3.6 WBGene00015552 C06G3.6 
F49E11.1 WBGene00003150 mbk-2 C17E7.4 WBGene00015899 C17E7.4 
F49E11.1 WBGene00003150 mbk-2 C17H12.9 WBGene00015934 ceh-48 
F49E11.1 WBGene00003150 mbk-2 C30H7.2 WBGene00016278 C30H7.2 
F49E11.1 WBGene00003150 mbk-2 C33H5.7 WBGene00016374 swd-2.2 
F49E11.1 WBGene00003150 mbk-2 C35E7.6 WBGene00016458 C35E7.6 
F49E11.1 WBGene00003150 mbk-2 C41H7.4 WBGene00016574 C41H7.4 
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Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
F49E11.1 WBGene00003150 mbk-2 C49H3.4 WBGene00016791 C49H3.4 
F49E11.1 WBGene00003150 mbk-2 C50F2.2 WBGene00016836 C50F2.2 
F49E11.1 WBGene00003150 mbk-2 F09G2.8 WBGene00017316 F09G2.8 
F49E11.1 WBGene00003150 mbk-2 F10E9.3 WBGene00017355 F10E9.3 
F49E11.1 WBGene00003150 mbk-2 F13B9.1 WBGene00017419 F13B9.1 
F49E11.1 WBGene00003150 mbk-2 F20D12.4 WBGene00017643 czw-1 
F49E11.1 WBGene00003150 mbk-2 F35H10.7 WBGene00018072 nprl-3 
F49E11.1 WBGene00003150 mbk-2 F39C12.1 WBGene00018193 F39C12.1 
F49E11.1 WBGene00003150 mbk-2 F41H10.6 WBGene00018319 hda-6 
F49E11.1 WBGene00003150 mbk-2 F44B9.8 WBGene00018409 F44B9.8 
F49E11.1 WBGene00003150 mbk-2 F44E2.7 WBGene00018420 F44E2.7 
F49E11.1 WBGene00003150 mbk-2 F49E8.1 WBGene00018635 nprl-2 
F49E11.1 WBGene00003150 mbk-2 F55G1.9 WBGene00018904 F55G1.9 
F49E11.1 WBGene00003150 mbk-2 H05C05.1 WBGene00019157 H05C05.1 
F49E11.1 WBGene00003150 mbk-2 K07B1.5 WBGene00019465 acl-14 
F49E11.1 WBGene00003150 mbk-2 K09H11.3 WBGene00019600 rga-3 
F49E11.1 WBGene00003150 mbk-2 R09A1.1 WBGene00019971 ergo-1 
F49E11.1 WBGene00003150 mbk-2 T10F2.2 WBGene00020422 T10F2.2 
F49E11.1 WBGene00003150 mbk-2 T19B4.5 WBGene00020558 T19B4.5 
F49E11.1 WBGene00003150 mbk-2 T21E3.1 WBGene00020652 egg-4 
F49E11.1 WBGene00003150 mbk-2 T22D1.10 WBGene00020687 ruvb-2 
F49E11.1 WBGene00003150 mbk-2 Y25C1A.6 WBGene00021293 Y25C1A.6 
F49E11.1 WBGene00003150 mbk-2 Y32H12A.8 WBGene00021316 Y32H12A.8 
F49E11.1 WBGene00003150 mbk-2 Y67D8C.5 WBGene00022069 eel-1 
F49E11.1 WBGene00003150 mbk-2 Y77E11A.1 WBGene00022306 Y77E11A.1 
F49E11.1 WBGene00003150 mbk-2 ZK1236.3 WBGene00023405 sor-1 
F49E11.1 WBGene00003150 mbk-2 ZK662.4 WBGene00023497 lin-15B 
F58B6.3 WBGene00003917 par-2 F48F7.1 WBGene00000105 alg-1 
F58B6.3 WBGene00003917 par-2 Y56A3A.20 WBGene00000369 ccf-1 
F58B6.3 WBGene00003917 par-2 T05G5.3 WBGene00000405 cdk-1 
F58B6.3 WBGene00003917 par-2 F55H2.6 WBGene00000550 clu-1 
F58B6.3 WBGene00003917 par-2 Y49A3A.5 WBGene00000877 cyn-1 
F58B6.3 WBGene00003917 par-2 B0252.4 WBGene00000886 cyn-10 
F58B6.3 WBGene00003917 par-2 K12H4.8 WBGene00000939 dcr-1 
F58B6.3 WBGene00003917 par-2 K02F2.1 WBGene00001056 dpf-3 
F58B6.3 WBGene00003917 par-2 R160.1 WBGene00001082 dpy-23 
F58B6.3 WBGene00003917 par-2 M04B2.3 WBGene00001585 gfl-1 
F58B6.3 WBGene00003917 par-2 ZC308.1 WBGene00001596 gld-2 
F58B6.3 WBGene00003917 par-2 F22B7.13 WBGene00001688 gpr-1 
F58B6.3 WBGene00003917 par-2 F08G12.10 WBGene00002124 inx-2 
F58B6.3 WBGene00003917 par-2 Y43F4B.6 WBGene00002229 klp-19 
F58B6.3 WBGene00003917 par-2 T19E10.1 WBGene00002297 ect-2 
F58B6.3 WBGene00003917 par-2 B0261.2 WBGene00002583 let-363 
F58B6.3 WBGene00003917 par-2 F28F8.3 WBGene00003079 lsm-5 
F58B6.3 WBGene00003917 par-2 ZK858.4 WBGene00003209 mel-26 
F58B6.3 WBGene00003917 par-2 W02A2.7 WBGene00003230 mex-5 
F58B6.3 WBGene00003917 par-2 F45H11.2 WBGene00003587 ned-8 
F58B6.3 WBGene00003917 par-2 K12D12.2 WBGene00003789 npp-3 
F58B6.3 WBGene00003917 par-2 Y37E3.15 WBGene00003799 npp-13 
F58B6.3 WBGene00003917 par-2 C15H11.3 WBGene00003834 nxf-1 
F58B6.3 WBGene00003917 par-2 H39E23.1 WBGene00003916 par-1 
F58B6.3 WBGene00003917 par-2 F54E7.3 WBGene00003918 par-3 
F58B6.3 WBGene00003917 par-2 T26E3.3 WBGene00003921 par-6 
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F58B6.3 WBGene00003917 par-2 F09E5.1 WBGene00004034 pkc-3 
F58B6.3 WBGene00003917 par-2 C18E9.3 WBGene00004105 szy-20 
F58B6.3 WBGene00003917 par-2 K08D10.4 WBGene00004385 rnp-2 
F58B6.3 WBGene00003917 par-2 F18E2.3 WBGene00004738 scc-3 
F58B6.3 WBGene00003917 par-2 Y113G7A.3 WBGene00004754 sec-23 
F58B6.3 WBGene00003917 par-2 Y116A8C.36 WBGene00006405 itsn-1 
F58B6.3 WBGene00003917 par-2 R09B3.4 WBGene00006707 ubc-12 
F58B6.3 WBGene00003917 par-2 Y40G12A.1 WBGene00006723 ubh-3 
F58B6.3 WBGene00003917 par-2 K11E8.1 WBGene00006779 unc-43 
F58B6.3 WBGene00003917 par-2 Y48B6A.3 WBGene00006964 xrn-2 
F58B6.3 WBGene00003917 par-2 Y111B2A.22 WBGene00007027 ssl-1 
F58B6.3 WBGene00003917 par-2 T04D1.4 WBGene00007053 chd-7 
F58B6.3 WBGene00003917 par-2 C47G2.5 WBGene00008166 saps-1 
F58B6.3 WBGene00003917 par-2 D2030.2 WBGene00008412 D2030.2 
F58B6.3 WBGene00003917 par-2 D2045.2 WBGene00008422 D2045.2 
F58B6.3 WBGene00003917 par-2 F10C2.4 WBGene00008645 F10C2.4 
F58B6.3 WBGene00003917 par-2 F13D12.5 WBGene00008740 F13D12.5 
F58B6.3 WBGene00003917 par-2 F43G9.1 WBGene00009664 idha-1 
F58B6.3 WBGene00003917 par-2 F45E6.3 WBGene00009726 tbc-13 
F58B6.3 WBGene00003917 par-2 F46B6.12 WBGene00009776 F46B6.12 
F58B6.3 WBGene00003917 par-2 F58G1.1 WBGene00010263 wago-4 
F58B6.3 WBGene00003917 par-2 K11E4.4 WBGene00010776 pix-1 
F58B6.3 WBGene00003917 par-2 R07H5.2 WBGene00011122 cpt-2 
F58B6.3 WBGene00003917 par-2 R53.2 WBGene00011272 R53.2 
F58B6.3 WBGene00003917 par-2 T01G1.3 WBGene00011338 sec-31 
F58B6.3 WBGene00003917 par-2 T05H10.1 WBGene00011507 T05H10.1 
F58B6.3 WBGene00003917 par-2 T11F9.14 WBGene00011715 T11F9.14 
F58B6.3 WBGene00003917 par-2 T12D8.2 WBGene00011730 drr-2 
F58B6.3 WBGene00003917 par-2 T27A8.3 WBGene00012075 T27A8.3 
F58B6.3 WBGene00003917 par-2 W04A4.5 WBGene00012234 W04A4.5 
F58B6.3 WBGene00003917 par-2 Y49E10.2 WBGene00013029 glrx-5 
F58B6.3 WBGene00003917 par-2 Y52D3.1 WBGene00013132 strd-1 
F58B6.3 WBGene00003917 par-2 Y57A10A.26 WBGene00013266 Y57A10A.26 
F58B6.3 WBGene00003917 par-2 Y113G7B.16 WBGene00013765 cdkr-3 
F58B6.3 WBGene00003917 par-2 ZC412.3 WBGene00013884 ZC412.3 
F58B6.3 WBGene00003917 par-2 ZK637.5 WBGene00014025 asna-1 
F58B6.3 WBGene00003917 par-2 ZK1098.4 WBGene00014221 ZK1098.4 
F58B6.3 WBGene00003917 par-2 ZK1320.9 WBGene00014258 ZK1320.9 
F58B6.3 WBGene00003917 par-2 B0336.3 WBGene00015143 B0336.3 
F58B6.3 WBGene00003917 par-2 B0403.4 WBGene00015168 pdi-6 
F58B6.3 WBGene00003917 par-2 C01G5.6 WBGene00015308 C01G5.6 
F58B6.3 WBGene00003917 par-2 C06E7.3 WBGene00015540 sams-4 
F58B6.3 WBGene00003917 par-2 C28H8.9 WBGene00016200 dpff-1 
F58B6.3 WBGene00003917 par-2 C34D4.14 WBGene00016405 hecd-1 
F58B6.3 WBGene00003917 par-2 F01F1.4 WBGene00017161 rabn-5 
F58B6.3 WBGene00003917 par-2 F07F6.4 WBGene00017217 F07F6.4 
F58B6.3 WBGene00003917 par-2 F15B10.3 WBGene00017481 F15B10.3 
F58B6.3 WBGene00003917 par-2 F40E3.2 WBGene00018230 mage-1 
F58B6.3 WBGene00003917 par-2 F53H1.1 WBGene00018776 F53H1.1 
F58B6.3 WBGene00003917 par-2 F53H1.4 WBGene00018778 F53H1.4 
F58B6.3 WBGene00003917 par-2 F56C9.10 WBGene00018953 F56C9.10 
F58B6.3 WBGene00003917 par-2 H24K24.3 WBGene00019240 H24K24.3 
F58B6.3 WBGene00003917 par-2 R02D3.5 WBGene00019823 fnta-1 
 VII Supplementary Information    
 
111 | P a g e  
 
Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
F58B6.3 WBGene00003917 par-2 R09A1.1 WBGene00019971 ergo-1 
F58B6.3 WBGene00003917 par-2 R13F6.1 WBGene00020064 kbp-1 
F58B6.3 WBGene00003917 par-2 Y34D9A.10 WBGene00021334 vps-4 
F58B6.3 WBGene00003917 par-2 Y42H9AR.1 WBGene00021536 Y42H9AR.1 
F58B6.3 WBGene00003917 par-2 Y48G8AL.5 WBGene00021686 Y48G8AL.5 
F58B6.3 WBGene00003917 par-2 Y66H1A.2 WBGene00022044 dpm-1 
F58B6.3 WBGene00003917 par-2 Y119D3B.11 WBGene00022488 orc-3 
F58B6.3 WBGene00003917 par-2 ZK688.5 WBGene00022800 ZK688.5 
T26E3.3 WBGene00003921 par-6 Y38C1AA.2 WBGene00000815 csn-3 
T26E3.3 WBGene00003921 par-6 ZK520.4 WBGene00000837 cul-2 
T26E3.3 WBGene00003921 par-6 F29D11.1 WBGene00003071 lrp-1 
T26E3.3 WBGene00003921 par-6 K08A8.1 WBGene00003185 mek-1 
T26E3.3 WBGene00003921 par-6 F54E7.3 WBGene00003918 par-3 
T26E3.3 WBGene00003921 par-6 C10F3.5 WBGene00003954 pcm-1 
T26E3.3 WBGene00003921 par-6 F09E5.1 WBGene00004034 pkc-3 
T26E3.3 WBGene00003921 par-6 D2030.2 WBGene00008412 D2030.2 
T26E3.3 WBGene00003921 par-6 F35B12.5 WBGene00009385 sas-5 
T26E3.3 WBGene00003921 par-6 ZK1320.9 WBGene00014258 ZK1320.9 
T26E3.3 WBGene00003921 par-6 C25B8.4 WBGene00016088 clec-266 
T26E3.3 WBGene00003921 par-6 C30H7.2 WBGene00016278 C30H7.2 
T26E3.3 WBGene00003921 par-6 F56F10.4 WBGene00018987 lgl-1 
T26E3.3 WBGene00003921 par-6 Y38F2AR.5 WBGene00021423 tftc-1 
C18G1.4 WBGene00003994 pgl-3 T05H4.13 WBGene00000110 alh-4 
C18G1.4 WBGene00003994 pgl-3 C35D10.9 WBGene00000418 ced-4 
C18G1.4 WBGene00003994 pgl-3 Y47G6A.8 WBGene00000794 crn-1 
C18G1.4 WBGene00003994 pgl-3 R01H10.1 WBGene00001002 div-1 
C18G1.4 WBGene00003994 pgl-3 K02F2.1 WBGene00001056 dpf-3 
C18G1.4 WBGene00003994 pgl-3 M04B2.3 WBGene00001585 gfl-1 
C18G1.4 WBGene00003994 pgl-3 T05A7.4 WBGene00001976 hmg-11 
C18G1.4 WBGene00003994 pgl-3 F53A2.6 WBGene00002059 ife-1 
C18G1.4 WBGene00003994 pgl-3 C05D11.12 WBGene00002855 let-721 
C18G1.4 WBGene00003994 pgl-3 T27C10.6 WBGene00003068 lrk-1 
C18G1.4 WBGene00003994 pgl-3 Y71G12B.20 WBGene00003111 mab-20 
C18G1.4 WBGene00003994 pgl-3 T01G9.5 WBGene00003183 mei-1 
C18G1.4 WBGene00003994 pgl-3 Y56A3A.1 WBGene00003826 ntl-3 
C18G1.4 WBGene00003994 pgl-3 ZK381.4 WBGene00003992 pgl-1 
C18G1.4 WBGene00003994 pgl-3 Y75B8A.30 WBGene00004085 pph-4.1 
C18G1.4 WBGene00003994 pgl-3 Y110A7A.18 WBGene00004094 ppw-2 
C18G1.4 WBGene00003994 pgl-3 D2030.6 WBGene00004178 prg-1 
C18G1.4 WBGene00003994 pgl-3 K11E8.1 WBGene00006779 unc-43 
C18G1.4 WBGene00003994 pgl-3 C04H5.1 WBGene00007312 C04H5.1 
C18G1.4 WBGene00003994 pgl-3 C31C9.2 WBGene00007836 C31C9.2 
C18G1.4 WBGene00003994 pgl-3 C36B1.3 WBGene00007971 rpb-3 
C18G1.4 WBGene00003994 pgl-3 F14E5.2 WBGene00008800 F14E5.2 
C18G1.4 WBGene00003994 pgl-3 F35B12.5 WBGene00009385 sas-5 
C18G1.4 WBGene00003994 pgl-3 F58G1.1 WBGene00010263 wago-4 
C18G1.4 WBGene00003994 pgl-3 M01E5.6 WBGene00010808 sepa-1 
C18G1.4 WBGene00003994 pgl-3 R06C7.1 WBGene00011061 wago-1 
C18G1.4 WBGene00003994 pgl-3 R07H5.2 WBGene00011122 cpt-2 
C18G1.4 WBGene00003994 pgl-3 T09A5.9 WBGene00011637 sds-22 
C18G1.4 WBGene00003994 pgl-3 T28C6.7 WBGene00012121 T28C6.7 
C18G1.4 WBGene00003994 pgl-3 Y47D3B.9 WBGene00012943 bed-2 
C18G1.4 WBGene00003994 pgl-3 ZK1098.1 WBGene00014218 ZK1098.1 
 VII Supplementary Information    
 
112 | P a g e  
 
Bait_ID Bait_WB_ID Bait_symbol Prey_ID Prey_WB_ID Prey_symbol 
C18G1.4 WBGene00003994 pgl-3 B0261.7 WBGene00015095 B0261.7 
C18G1.4 WBGene00003994 pgl-3 C10G11.7 WBGene00015687 C10G11.7 
C18G1.4 WBGene00003994 pgl-3 C34B2.6 WBGene00016391 C34B2.6 
C18G1.4 WBGene00003994 pgl-3 C50E3.12 WBGene00016823 C50E3.12 
C18G1.4 WBGene00003994 pgl-3 F53B1.4 WBGene00018737 F53B1.4 
C18G1.4 WBGene00003994 pgl-3 H28G03.1 WBGene00019249 H28G03.1 
C18G1.4 WBGene00003994 pgl-3 K10C2.4 WBGene00019620 fah-1 
C18G1.4 WBGene00003994 pgl-3 R13F6.10 WBGene00020068 cra-1 
C18G1.4 WBGene00003994 pgl-3 T09B4.9 WBGene00020383 T09B4.9 
C18G1.4 WBGene00003994 pgl-3 W02D3.2 WBGene00020932 dhod-1 
C18G1.4 WBGene00003994 pgl-3 Y4C6B.1 WBGene00021155 Y4C6B.1 
C18G1.4 WBGene00003994 pgl-3 Y39G10AR.10 WBGene00021468 epg-2 
C18G1.4 WBGene00003994 pgl-3 Y65B4BL.5 WBGene00022037 acs-13 
C18G1.4 WBGene00003994 pgl-3 Y104H12D.2 WBGene00022426 Y104H12D.2 
Y49E10.14 WBGene00004027 pie-1 T07D3.7 WBGene00000106 alg-2 
Y49E10.14 WBGene00004027 pie-1 ZC308.1 WBGene00001596 gld-2 
Y49E10.14 WBGene00004027 pie-1 T07F8.3 WBGene00001597 gld-3 
Y49E10.14 WBGene00004027 pie-1 C53A5.3 WBGene00001834 hda-1 
Y49E10.14 WBGene00004027 pie-1 W03C9.7 WBGene00003228 mex-1 
Y49E10.14 WBGene00004027 pie-1 ZC302.1 WBGene00003405 mre-11 
Y49E10.14 WBGene00004027 pie-1 C49H3.5 WBGene00003827 ntl-4 
Y49E10.14 WBGene00004027 pie-1 C07G1.5 WBGene00004101 hgrs-1 
Y49E10.14 WBGene00004027 pie-1 R09A8.3 WBGene00006493 tag-147 
Y49E10.14 WBGene00004027 pie-1 W09C5.2 WBGene00006793 unc-59 
Y49E10.14 WBGene00004027 pie-1 F35G2.2 WBGene00009436 marb-1 
Y49E10.14 WBGene00004027 pie-1 F43G9.5 WBGene00009668 cfim-1 
Y49E10.14 WBGene00004027 pie-1 T04D3.2 WBGene00011432 sdz-30 
Y49E10.14 WBGene00004027 pie-1 Y17G7B.3 WBGene00012459 Y17G7B.3 
Y49E10.14 WBGene00004027 pie-1 ZK1098.11 WBGene00014226 ZK1098.11 
Y49E10.14 WBGene00004027 pie-1 B0041.2 WBGene00015007 ain-2 
Y49E10.14 WBGene00004027 pie-1 C06G1.4 WBGene00015547 ain-1 
Y49E10.14 WBGene00004027 pie-1 C30H7.2 WBGene00016278 C30H7.2 
Y49E10.14 WBGene00004027 pie-1 C34B2.7 WBGene00016392 sdha-2 
Y49E10.14 WBGene00004027 pie-1 C45E1.4 WBGene00016663 C45E1.4 
Y49E10.14 WBGene00004027 pie-1 F41H10.6 WBGene00018319 hda-6 
Y49E10.14 WBGene00004027 pie-1 F48E3.3 WBGene00018604 uggt-1 
Y49E10.14 WBGene00004027 pie-1 W07E6.1 WBGene00021073 nol-1 
M03D4.1 WBGene00006974 zen-4 H15N14.1 WBGene00000079 adr-1 
M03D4.1 WBGene00006974 zen-4 F27C1.7 WBGene00000230 atp-3 
M03D4.1 WBGene00006974 zen-4 T03E6.7 WBGene00000776 cpl-1 
M03D4.1 WBGene00006974 zen-4 K08E3.6 WBGene00000875 cyk-4 
M03D4.1 WBGene00006974 zen-4 F36H9.3 WBGene00000976 dhs-13 
M03D4.1 WBGene00006974 zen-4 C25F6.2 WBGene00001006 dlg-1 
M03D4.1 WBGene00006974 zen-4 F54D5.8 WBGene00001031 dnj-13 
M03D4.1 WBGene00006974 zen-4 T05C3.5 WBGene00001037 dnj-19 
M03D4.1 WBGene00006974 zen-4 T15H9.7 WBGene00001038 dnj-20 
M03D4.1 WBGene00006974 zen-4 ZK328.2 WBGene00001166 eftu-2 
M03D4.1 WBGene00006974 zen-4 C46A5.9 WBGene00001827 hcf-1 
M03D4.1 WBGene00006974 zen-4 C53A5.3 WBGene00001834 hda-1 
M03D4.1 WBGene00006974 zen-4 F26D10.3 WBGene00002005 hsp-1 
M03D4.1 WBGene00006974 zen-4 C37H5.8 WBGene00002010 hsp-6 
M03D4.1 WBGene00006974 zen-4 F53A2.6 WBGene00002059 ife-1 
M03D4.1 WBGene00006974 zen-4 B0348.6 WBGene00002061 ife-3 
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M03D4.1 WBGene00006974 zen-4 F26B1.3 WBGene00002073 ima-2 
M03D4.1 WBGene00006974 zen-4 C02F5.1 WBGene00002231 knl-1 
M03D4.1 WBGene00006974 zen-4 Y71H2AM.19 WBGene00002244 laf-1 
M03D4.1 WBGene00006974 zen-4 F26F12.7 WBGene00002637 let-418 
M03D4.1 WBGene00006974 zen-4 T09A5.10 WBGene00002994 lin-5 
M03D4.1 WBGene00006974 zen-4 T27C4.4 WBGene00003025 lin-40 
M03D4.1 WBGene00006974 zen-4 C25D7.6 WBGene00003155 mcm-3 
M03D4.1 WBGene00006974 zen-4 F26F4.7 WBGene00003598 nhl-2 
M03D4.1 WBGene00006974 zen-4 T19B4.2 WBGene00003793 npp-7 
M03D4.1 WBGene00006974 zen-4 C49H3.5 WBGene00003827 ntl-4 
M03D4.1 WBGene00006974 zen-4 F48E8.5 WBGene00003901 paa-1 
M03D4.1 WBGene00006974 zen-4 C17E4.5 WBGene00003904 pabp-2 
M03D4.1 WBGene00006974 zen-4 C10F3.5 WBGene00003954 pcm-1 
M03D4.1 WBGene00006974 zen-4 W03D2.4 WBGene00003955 pcn-1 
M03D4.1 WBGene00006974 zen-4 Y37E3.9 WBGene00004014 phb-1 
M03D4.1 WBGene00006974 zen-4 F45E4.2 WBGene00004046 plp-1 
M03D4.1 WBGene00006974 zen-4 Y76A2B.1 WBGene00004075 pod-1 
M03D4.1 WBGene00006974 zen-4 C07G1.5 WBGene00004101 hgrs-1 
M03D4.1 WBGene00006974 zen-4 F44B9.7 WBGene00004125 mdt-30 
M03D4.1 WBGene00006974 zen-4 T20H4.3 WBGene00004189 pars-1 
M03D4.1 WBGene00006974 zen-4 F01G4.1 WBGene00004204 swsn-4 
M03D4.1 WBGene00006974 zen-4 T23G5.1 WBGene00004391 rnr-1 
M03D4.1 WBGene00006974 zen-4 F57B9.10 WBGene00004462 rpn-6.1 
M03D4.1 WBGene00006974 zen-4 C52E4.4 WBGene00004501 rpt-1 
M03D4.1 WBGene00006974 zen-4 Y49E10.1 WBGene00004506 rpt-6 
M03D4.1 WBGene00006974 zen-4 W02B12.2 WBGene00004699 rsp-2 
M03D4.1 WBGene00006974 zen-4 ZK652.1 WBGene00004918 snr-5 
M03D4.1 WBGene00006974 zen-4 B0336.9 WBGene00006359 swp-1 
M03D4.1 WBGene00006974 zen-4 F42A8.2 WBGene00006433 sdhb-1 
M03D4.1 WBGene00006974 zen-4 T27E9.1 WBGene00006439 ant-1.1 
M03D4.1 WBGene00006974 zen-4 C14B1.4 WBGene00006474 wdr-5.1 
M03D4.1 WBGene00006974 zen-4 D1054.15 WBGene00006481 plrg-1 
M03D4.1 WBGene00006974 zen-4 C36E8.5 WBGene00006537 tbb-2 
M03D4.1 WBGene00006974 zen-4 F58A4.8 WBGene00006540 tbg-1 
M03D4.1 WBGene00006974 zen-4 F39H11.2 WBGene00006577 tlf-1 
M03D4.1 WBGene00006974 zen-4 Y92C3B.2 WBGene00006697 uaf-1 
M03D4.1 WBGene00006974 zen-4 W02D3.9 WBGene00006773 unc-37 
M03D4.1 WBGene00006974 zen-4 W09C5.2 WBGene00006793 unc-59 
M03D4.1 WBGene00006974 zen-4 Y50E8A.4 WBGene00006795 unc-61 
M03D4.1 WBGene00006974 zen-4 C27H6.2 WBGene00007784 ruvb-1 
M03D4.1 WBGene00006974 zen-4 C36A4.5 WBGene00007966 C36A4.5 
M03D4.1 WBGene00006974 zen-4 C37E2.1 WBGene00007993 idhb-1 
M03D4.1 WBGene00006974 zen-4 F11A10.2 WBGene00008683 repo-1 
M03D4.1 WBGene00006974 zen-4 F25D7.4 WBGene00009113 F25D7.4 
M03D4.1 WBGene00006974 zen-4 F32B6.2 WBGene00009319 mccc-1 
M03D4.1 WBGene00006974 zen-4 F35G2.2 WBGene00009436 marb-1 
M03D4.1 WBGene00006974 zen-4 F38E11.5 WBGene00009542 copb-2 
M03D4.1 WBGene00006974 zen-4 F44E5.1 WBGene00009688 F44E5.1 
M03D4.1 WBGene00006974 zen-4 F45G2.4 WBGene00009732 cope-1 
M03D4.1 WBGene00006974 zen-4 F53A2.7 WBGene00009952 F53A2.7 
M03D4.1 WBGene00006974 zen-4 F54B3.3 WBGene00010015 atad-3 
M03D4.1 WBGene00006974 zen-4 K08E3.5 WBGene00010665 K08E3.5 
M03D4.1 WBGene00006974 zen-4 M18.5 WBGene00010890 ddb-1 
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M03D4.1 WBGene00006974 zen-4 R07E5.3 WBGene00011111 snfc-5 
M03D4.1 WBGene00006974 zen-4 T10B10.2 WBGene00011679 ucr-2.2 
M03D4.1 WBGene00006974 zen-4 T20G5.1 WBGene00011867 chc-1 
M03D4.1 WBGene00006974 zen-4 Y54G9A.6 WBGene00013209 bub-3 
M03D4.1 WBGene00006974 zen-4 Y54G11A.13 WBGene00013220 ctl-3 
M03D4.1 WBGene00006974 zen-4 Y57G11C.34 WBGene00013324 mrps-7 
M03D4.1 WBGene00006974 zen-4 ZK669.4 WBGene00014054 ZK669.4 
M03D4.1 WBGene00006974 zen-4 B0303.3 WBGene00015125 B0303.3 
M03D4.1 WBGene00006974 zen-4 B0403.4 WBGene00015168 pdi-6 
M03D4.1 WBGene00006974 zen-4 C25B8.4 WBGene00016088 clec-266 
M03D4.1 WBGene00006974 zen-4 C44B7.10 WBGene00016630 C44B7.10 
M03D4.1 WBGene00006974 zen-4 F20D12.4 WBGene00017643 czw-1 
M03D4.1 WBGene00006974 zen-4 F38A5.7 WBGene00018164 sup-36 
M03D4.1 WBGene00006974 zen-4 F44B9.8 WBGene00018409 F44B9.8 
M03D4.1 WBGene00006974 zen-4 F48E3.3 WBGene00018604 uggt-1 
M03D4.1 WBGene00006974 zen-4 F49D11.1 WBGene00018625 prp-17 
M03D4.1 WBGene00006974 zen-4 F56F11.4 WBGene00018991 F56F11.4 
M03D4.1 WBGene00006974 zen-4 F57B10.14 WBGene00019007 F57B10.14 
M03D4.1 WBGene00006974 zen-4 H28G03.1 WBGene00019249 H28G03.1 
M03D4.1 WBGene00006974 zen-4 R07G3.5 WBGene00019941 pgam-5 
M03D4.1 WBGene00006974 zen-4 R119.3 WBGene00020089 R119.3 
M03D4.1 WBGene00006974 zen-4 T10F2.4 WBGene00020423 prp-19 
M03D4.1 WBGene00006974 zen-4 T19B4.5 WBGene00020558 T19B4.5 
M03D4.1 WBGene00006974 zen-4 T20F5.6 WBGene00020628 T20F5.6 
M03D4.1 WBGene00006974 zen-4 T22D1.10 WBGene00020687 ruvb-2 
M03D4.1 WBGene00006974 zen-4 T24C4.1 WBGene00020757 ucr-2.3 
M03D4.1 WBGene00006974 zen-4 Y39G10AR.2 WBGene00021460 zwl-1 
M03D4.1 WBGene00006974 zen-4 Y47G6A.24 WBGene00021648 mis-12 
M03D4.1 WBGene00006974 zen-4 Y55F3AR.3 WBGene00021934 cct-8 
M03D4.1 WBGene00006974 zen-4 Y61A9LA.8 WBGene00022019 sut-2 
M03D4.1 WBGene00006974 zen-4 Y65B4A.6 WBGene00022029 Y65B4A.6 
M03D4.1 WBGene00006974 zen-4 Y71F9AL.9 WBGene00022114 Y71F9AL.9 
M03D4.1 WBGene00006974 zen-4 ZK616.4 WBGene00022774 swsn-6 
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